SarcomaBCB data dictionary

Patient (15 items)

Centre (ConticaBase)
Type : Constrained
Content : TEXT
Mandatory : Yes
Multiple values : No
Unique : No		 Description : Centre ConticaBase Possible values :
MEDIPATH Toulouse, Cabinet de Reims, Centre Patho de Metz, Cabinet de Douai, Cabinet d’Amiens, IHP Nantes, Centre Patho Dijon, Cabinet de la Roquette, Cabinet Mathurin, Lyon CLB, Hôp. Gabriel Montpied, CHRU De Dijon, Hôp. Pontchaillou, Hôp. Charles Nicolle, Hôp Pasteur, CHU Amiens, Labo. de Limoges, Service d'anapath de Brest, Cy-Path, Cabinet de Rennes, Villejuif IGR, Milan INT, Padova UNIPD, KLEUVEN, CHRU Lille, Saint-Louis, Bergonié, Curie, Mannheim, Nice CAL, Dijon CGFL, Caen CFB, Marseille IPC, Nancy ICL, Lille COL, Lausanne, Montpellier ICM, Angers ICO, Nantes ICO , IUCT Toulouse, Strasbourg CHU, Bruxelles, CJP, Paris Henri Mondor, Warsaw Cancer Center, Timone, Cochin, Rennes CEM, Heidelberg, Bonn, Tübingen, Haut-Lévèque Bordeaux, LUMC, Ambroise Paré APHP, Nantes CHU, Tours Trousseau, CPS Strasbourg, CHRU Montpellier, Limoges Dupuytren, Rouen CHB, Lyon IHOP, St Etienne ICLN-CHU, Reims IJG, Reims CHU, Besançon CHU, La Réunion CHU, Tenon, Bicêtre, Pitié Salpétrière, GHSN - LYON, Hôp. Civil Strasbourg, CHRU Caen, CHRU Brest, CHU Nancy, Rangueil Toulouse, Purpan Toulouse, Centre Hospitalier - Lille, CHRU Angers, Hôp. Nord Marseille, MEDIPATH (Frejus), APHP Bichat, APHP Saint-Antoine, Bordeaux Pellegrin, Lyon Edouard Herriot, CHR ORLEANS, Nice CHU, Cabinet Bièvres, CHU POITIERS, OUEST PATHOLOGIE, DIAG (Nice), GRP 2 RIVES, HPL, Centre François Baclesse Luxembourg, CHU ESTAIN , MEDIPATH (Toulon)
File number
Type : Free value
Content : TEXT
Mandatory : Yes
Multiple values : No
Unique : Yes		 Description : The unique file number the patient has in his centre
Birth date
Type : Free value
Content : DATE
Mandatory : Yes
Multiple values : No
Unique : No		 Description : The patient's birth date
Sex
Type : Constrained
Content : TEXT
Mandatory : Yes
Multiple values : No
Unique : No		 Description : The patient's gender Possible values :
Female, Male
Creation date patient
Type : Free value
Content : DATE
Mandatory : Yes
Multiple values : No
Unique : No		 Description : The date when the patient has been created in the database
Significant previous history
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No		 Description : No: no significant previous historyNF1: presence of neurofibromatosis type 1 or Recklinghausen diseaseNF2: presence of neurofibromatosis type 2Radiation therapy: tumour developed in a previously radiated areaLymphoedema: tumour developed on a preexisting lymphoedemaGardner: presence of a Gardner syndromLi Fraumeni: presence of a Li Fraumeni diseasePrevious cancer: the patient has previously developed another cancer different from the current tumourOther: other significant previous history with a possible link with the current tumour Possible values :
No, Previous cancer, NF1, NF2, Gardner syndrome, Li Fraumeni syndrome, Retinoblastoma syndrome, Immunodepressed - HIV, Immunodepressed - other, Ollier disease, Maffucci syndrome, Paget disease, Multiple osteochondromas, McCune-Albright syndrome, Rothmund-Thomson syndrome, Werner syndrome, Cherubism, Other genetic disease, Other, Unknown, Familial GISTs, Stratiakis-Carney dyad, Carney Triad, Other malignancy in family
Significant previous history detail
Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description :
Other cancer
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Has the patient another cancer Possible values :
Yes, No, Unknown
Date of last contact
Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No		 Description : Date of the last follow up evaluation or date of death
Lost of follow-up
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Lost of follow-up Possible values :
No, Yes
Vital status
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Vital status at last contact Possible values :
Alive, Dead
Cause of death
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Cause of death Possible values :
- Dead of this cancer
- Primary cancer
- Metastatic disease
- Dead of other cancer
- Dead of treatment complication
- Dead of other cause
- Unknown
Date of death
Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No		 Description :
Quality control Conticabase
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
No, Yes
Date of control
Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No		 Description :

Primary tumour (56 items)

Type of tumour
Type : Constrained
Content : TEXT
Mandatory : Yes
Multiple values : No
Unique : No		 Description : point de départ du développement de la tumeur<br> Possible values :
Soft tissue, Viscera, Bone
Site of tumour
Type : Constrained
Content : TEXT
Mandatory : Yes
Multiple values : No
Unique : No		 Description : Site of tumour according to the scroll menu Possible values :
- Soft tissue
- Head and neck
- Superficial areas of head
- Sinus and nasal fossa
- Deep facial areas
- Orbit
- Anterior skull base
- Ear - lateral skull base and nasoharynx
- Oral cavity - oropharynx
- Larynx - trachea
- Visceral space of the neck
- Neck NOS
- Other
- Trunk wall
- Chest wall
- Axilla
- Abdominal wall
- Trunk - paraspinal
- Buttock
- Groin
- Internal trunk
- Retroperitoneum
- Peritoneum
- Pelvis
- Thorax internal
- Large vessels
- Paratesticular
- Lower limb
- Thigh
- Knee
- Leg
- Ankle
- Foot
- Toe
- Upper limb
- Shoulder girdle
- Upper arm
- Elbow
- Forearm
- Wrist
- Hand
- Finger
- Viscera
- Gastro Intestinal tractus
- Oesophagus
- Stomach
- Duodenum
- Appendix
- Small intestine
- Colon
- Rectum
- Anus
- Gyneacological area
- Uterus
- Ovary
- Fallopian tube
- Vagina
- Vulva
- Others
- Breast
- Lung
- Heart
- Pleura
- Thymus
- Thyroid
- Kidney
- Bladder
- Ureter
- Prostate
- Testis
- Epididymis
- Penis
- Spleen
- Liver
- Pancreas
- Gallbladder
- Salivary gland
- Tonsil
- Adrenal
- Brain
- Meninges
- Lymph node
- Bone
- Skull and face bone
- Skull NOS
- Ethmoid
- Superior maxilla
- Mandible
- Bone face
- Upper airways
- Larynx
- Bronchus
- Nasal septum
- Spine
- Cervical spine
- Dorsal spine
- Lumbar spine
- Basin, sacrum, coccyx
- Basin
- Sacrum
- Coccyx
- Hip joint
- Other thoracic bone
- Rib
- Sternum
- Clavicle
- Superior limb and shoulder
- Bone shoulder girdle
- Scapula
- Shoulder joint
- Humerus
- Elbow joint
- Ulna
- Radius
- Wirst joint
- Hand bone NOS
- Carpal (Hand)
- Metacarpals (Hand)
- Hand phalanges
- Hand joint
- Inferior limb
- Femur
- Patella
- Knee joint
- Tibia
- Fibula
- Ankle joint
- Bone foot NOS
- Tarsals (Foot)
- Metatarsals (Foot)
- Foot phalanges
- Foot joint
Side (RESOS)
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Laterality of bone tumour in human body Possible values :
Left, Right, Median, Unspecified, Not applicable
Size of tumour (mm)
Type : Free value
Content : INTEGER
Mandatory : No
Multiple values : No
Unique : No		 Description : Largest diameter of the tumour expressed in mm
Depth of tumour
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Superficial: the tumour is located above the superficial aponeurosis with no involvement of this aponeurosis Deep: the tumour is located beneath the superficial aponeurosis with no involvement of the area above this aponeurosis. Involvement of the aponeurosis is possibleSuperficial and deep: the tumour is located above and beneath the superficial aponeurosis Possible values :
Superficial, Superficial and deep, Deep, Surface, Cortical, Intra-medullary
Histotype
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Histotype of the primary tumour to be chosen in the scroll menu (2013 WHO classification, 0) Possible values :
- Benign lesion
- Benign adipocytic tumours
- Angiolipoma
- Angiomyolipoma
- Chondroid lipoma
- Hibernoma
- Lipoblastoma/lipoblastomatosis
- Lipoma
- Lipomatosis
- Lipomatosis of nerve
- Atypical spindle cell/pleomorphic lipomatous tumour
- Myelolipoma
- Myolipoma
- Spindle cell / pleomorphic lipoma
- Benign chondrogenic tumours
- Chondroblastoma NOS
- Chondroma
- Chondromyxoid fibroma
- Enchondroma
- Osteochondroma
- Osteochondromyxoma
- Periosteal chondroma
- Pulmonary chondroma
- Pulmonary hamartoma
- Subungueal exostosis
- Synovial chondromatosis
- Benign fibroblastic/myofibroblastic tumours
- Adenofibroma
- Angiofibroma
- Angiomyofibroblastoma
- Calcifying aponeurotic fibroma
- Calcifying fibrous tumour
- Cellular angiofibroma
- Desmoplastic fibroblastoma
- Elastofibroma
- Fasciitis
- Fibroblastic tumour with SMAD3 fusion
- Fibrochondromyxoid tumour with THBS1 fusion
- Fibro-osseous pseudotumour of digits
- Fibroma of tendon sheath
- Fibromatosis colli
- Fibrous hamartoma of infancy
- Gardner fibroma
- Inclusion body fibromatosis
- Intra-nodal palisaded myofibroblastoma
- Ischaemic fasciitis
- Juvenile hyaline fibromatosis
- Myofibroblastoma
- Myositis ossificans
- Nasopharyngeal angiofibroma
- Nodular fasciitis
- Nuchal-type fibroma
- Organ-associated pseudosarcomatous myofibroblastic proliferations
- Other fibromas
- Proliferative fasciitis
- Proliferative myositis
- Benign fibro-histiocytic tumours
- Central giant cell granuloma of jaws (giant cell reparative granuloma of jaws)
- Deep benign fibrous histiocytoma
- Epithelioid fibrous histiocytoma
- Erdheim-Chester disease
- Fibrous histiocytoma
- Giant cell lesion of the small bones (extragnathic giant cell reparative granuloma)
- Langerhans cell histiocytosis
- Non Ossifying fibroma
- Rosai-Dorfman disease
- Tenosynovial giant cell tumour NOS
- Tenosynovial giant cell tumour, diffuse type
- Tenosynovial giant cell tumour, localized type
- Benign nerve sheath tumours
- Atypical neurofibromatous neoplasm of uncertain biological potential ANNUBP
- Benign Triton tumour
- Dermal nerve sheath myxoma
- Ectopic meningioma
- Granular cell tumour
- Hybrid nerve sheath tumours
- Nasal glial heterotopia
- Neurofibroma
- Neurothekeoma
- Perineurioma
- Plexiform neurofibroma
- Schwannoma
- Solitary circumscribed neuroma
- Benign notochordal tumour
- Benign osteogenic tumours
- Osteoid osteoma
- Osteoma
- Benign pericytic tumours
- Angioleiomyoma
- Glomus tumour
- Myofibroma / myofibromatosis
- Myopericytoma
- Benign skeletal muscle tumours
- Rhabdomyoma
- Rhabdomyoma - adult type
- Rhabdomyoma - fetal type
- Rhabdomyoma - genital type
- Benign smooth muscle tumours
- Atypical polypoid adenomyoma
- Adenomyoma
- Bizarre nuclei leiomyoma
- Cellular leiomyoma
- Diffuse leiomyomatosis
- Dissecans leiomyoma
- Epithelioid leiomyoma
- Intraveinous leiomyomatosis
- Leiomyoma
- Leiomyomatosis peritonealis disseminata
- Mitotically-active leiomyoma
- Myxoid leiomyoma
- Benign tumours of uncertain differentiation
- Acral fibromyxoma
- Brown tumour
- Deep (aggressive) angiomyxoma
- Ectopic hamartomatous thymoma
- Fibrous dysplasia
- Inflammatory fibroid polyp
- Intramuscular myxoma
- Myxoma NOS
- Osteofibrous dysplasia
- Pleomorphic hyalinizing angiectatic tumour
- Pleuropulmonary blastoma
- Simple bone cyst
- Superficial angiomyxoma
- Benign vascular tumours
- Angiolymphoid hyperplasia
- Angiomatosis
- Atypical vascular lesion
- Diffuse pulmonary lymphangiomatosis
- Epithelioid hemangioma
- Gorham disease
- Hemangioma
- Intra-muscular hemangioma
- Lymphangioma NOS
- Lymphangiomatosis
- Pyogenic granuloma
- Osseous pseudo-tumours
- Bizarre parosteal osteochondromatous proliferation
- Callus
- Florid ossificans periostitis
- Post-traumatic fibro-osseous lesion
- Tophaceous pseudogout
- Other benign lesion
- GIST
- gastrointestinal stromal tumour (GIST), low, very low risk
- gastrointestinal stromal tumour (GIST), intermediate risk
- gastrointestinal stromal tumour (GIST), high risk
- Non-mesenchymal malignant tumour
- Carcinoma
- Germinal tumor
- Lymphoma
- Melanoma
- Myeloma
- Other non-mesenchymal malignant tumours
- Plasmocytoma
- Other diagnoses
- Diagnosis unspecified
- Undifferentiated malignant tumour
- Sarcoma
- Chondrosarcoma
- Central chondrosarcoma
- Chondrosarcoma, grade 1
- Chondrosarcoma, grade 2
- Chondrosarcoma, grade 3
- Chondrosarcoma NOS
- Clear cell chondrosarcoma
- Dedifferentiated chondrosarcoma
- Mesenchymal chondrosarcoma
- Periosteal chondrosarcoma
- Peripheral chondrosarcoma
- Leiomyosarcoma
- Leiomyosarcoma - differentiated
- Leiomyosarcoma - epithelioid
- Leiomyosarcoma - myxoid
- Leiomyosarcoma - poorly-differentiated
- Liposarcoma
- Liposarcoma - dedifferentiated
- Liposarcoma - mixed type
- Liposarcoma - myxoid
- Liposarcoma - NOS
- Liposarcoma - pleomorphic
- Liposarcoma - round cell
- Liposarcoma - well differentiated
- Myxoid pleomorphic liposarcoma
- Malignant fibrohistiocytic tumours of bone
- Malignant giant cell tumour of bone
- Malignant peripheral nerve sheath tumour
- Ectomesenchymoma
- Malignant perineurioma
- Malignant Triton tumour
- MPNST - epithelioid type
- MPNST - usual type
- Miscellaneous sarcomas
- Alveolar soft part sarcoma
- Angiosarcoma
- BCOR sarcoma
- CIC-DUX sarcoma
- CIC-rearranged sarcoma
- Clear cell sarcoma
- Desmoplastic round cell tumour
- Epithelioid hemangioendothelioma NOS
- Epithelioid hemangioendothelioma with TFE3 fusion
- Epithelioid hemangioendothelioma with WWTR1 fusion
- Epithelioid sarcoma
- Ewing sarcoma
- Extraskeletal myxoid chondrosarcoma
- Fibrosarcoma NOS
- High risk solitary fibrous tumour
- Intimal sarcoma
- Low grade fibromyxoid sarcoma
- Low grade sinonasal sarcoma
- Malignant glomus tumour
- Malignant granular cell tumour
- Malignant mesenchymoma
- Malignant mixed tumor
- Malignant myoepithelial tumour
- Malignant ossifying fibromyxoid tumour
- Malignant PECOMA
- Malignant rhabdoid tumour
- Malignant tenosynovial giant cell tumour
- Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion
- Sclerosing epithelioid fibrosarcoma
- SMARCA4-deficient undifferentiated thoracic tumour
- Myxofibrosarcoma
- Osteosarcoma
- Conventional osteosarcoma
- Dedifferentiated low-grade central osteosarcoma
- Dedifferentiated parosteal osteosarcoma
- Extraskeletal osteosarcoma
- High-grade surface osteosarcoma
- Low-grade central osteosarcoma
- Osteoblastoma-like osteosarcoma
- Osteosarcoma NOS
- Parosteal osteosarcoma
- Periosteal osteosarcoma
- Small cell osteosarcoma
- Secondary osteosarcoma
- Telangiectasic osteosarcoma
- Other sarcomas
- Adamantinoma
- Adenosarcoma
- Chondroid chordoma
- Chordoma NOS
- Dedifferentiated adamantimoma
- Dedifferentiated chordoma
- Endometrial stromal sarcoma
- Endometrial stromal sarcoma - high-grade
- Endometrial stromal sarcoma - low-grade
- Phyllodes sarcoma
- Poorly differenciated chordoma
- Undifferentiated uterine sarcoma
- Rhabdomyosarcoma
- Adult spindle cell rhabdomyosarcoma
- Alveolar rhabdomyosarcoma
- Embryonal rhabdomyosarcoma - botryoid type
- Embryonal rhabdomyosarcoma - NOS
- Embryonal rhabdomyosarcoma - spindle cell type
- Embryonal rhabdomyosarcoma - usual type
- Pleomorphic rhabdomyosarcoma
- Rhabdomyosarcoma - NOS
- Rhabdomyosarcoma with MYOD1 mutation
- Rhabdomyosarcoma with TFCP2 fusion
- Rhabdomyosarcoma with VGLL2/NCOA2 fusion
- Sclerosing rhabdomyosarcoma
- Spindle cell rhabdomyosarcoma
- Suspicion of sarcoma
- Synovial sarcoma
- Synovial sarcoma - biphasic
- Synovial sarcoma - monophasic
- Synovial sarcoma - NOS
- Synovial sarcoma - poorly differentiated
- Undifferentiated sarcoma
- Undifferentiated epithelioid sarcoma
- Undifferentiated pleomorphic sarcoma
- Undifferentiated round cell sarcoma
- Undifferentiated sarcoma - NOS
- Undifferentiated spindle cell sarcoma
- Tumour of intermediate malignancy
- Atypical lipomatous tumour
- Intermediate chondrogenic tumours
- Atypical cartilaginous tumour
- Cartilaginous tumour of uncertain prognosis
- Chondromatosis NOS
- Intermediate fibroblastic/myofibroblastic tumours
- Dermatofibrosarcoma protuberans
- Desmoid-type fibromatosis
- Desmoplastic fibroma of bone
- Fibro-osseous tumour of bone NOS
- Fibrosarcomatous dermatofibrosarcoma protuberans
- Giant cell fibroblastoma
- Infantile fibrosarcoma
- Inflammatory myofibroblastic tumour
- Intermediate risk solitary fibrous tumour
- Lipofibromatosis
- Low grade myofibroblastic sarcoma
- Low risk solitary fibrous tumour
- Myxoinflammatory fibroblastic sarcoma
- NTRK-rearranged spindle cell neoplasm
- Palmar/plantar fibromatosis
- Superficial CD34-positive fibroblastic tumour
- Intermediate fibrohistiocytic tumours
- Giant cell tumour of bone
- Giant cell tumour of soft tissues
- Metastatic giant cell tumour of bone
- Osseous tumour rich in giant cell NOS
- Plexiform fibrohistiocytic tumour
- Suspicion of giant cell tumour of bone
- Intermediate osteogenic tumours
- Osteoblastoma NOS
- Osteogenic tumor of uncertain prognosis (osteoblastoma versus osteoblastoma-like osteosarcoma)
- Intermediate peripheral nerve sheath tumour
- Malignant melanotic neural tumour
- Intermediate tumours of uncertain differentiation
- Aneurysmal bone cyst
- Angiomatoid fibrous histiocytoma
- Atypical fibroxanthoma
- Cutaneous pleomorphic sarcoma
- Hemosiderotic fibrolipomatous tumour
- Lymphangioleiomyoma/lymphangioleiomyomatosis
- Malignant phosphaturic mesenchymal tumour
- Melanotic neuroectodermal tumour of infancy
- Mesenchymal tumor with GLI1 alteration
- Mixed tumour
- Myoepithelioma
- Ossifying fibromyxoid tumour
- PECOMA - NOS
- Phosphaturic mesenchymal tumour NOS
- Intermediate vascular tumours
- Composite hemangioendothelioma
- Epithelioid vascular tumour of bone NOS
- Kaposi sarcoma
- Kaposiform hemangioendothelioma
- Papillary intralymphatic angioendothelioma
- Pseudomyogenic hemangioendothelioma
- Retiform hemangioendothelioma
- Other tumours of intermediate malignancy
- Atypical smooth muscle tumour
- EBV-associated smooth muscle tumour (STUMP)
- Endometrial stromal nodule
- Endometrial stromal tumor low-grade
- Inflammatory rhabdomyoblastic tumour
- Metastatic leiomyoma
- Smooth muscle tumour of undetermined malignant potential (STUMP)
- Uterine tumour resembling ovarian sex cord tumours (UTROSCT)
- Other intermediate mesenchymal tumour of bone
- Mesenchymoma NOS
- Osteofibrous dysplasia-like adamantinoma
Date of original diagnosis
Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No		 Description : Date of the first sampling which allowed the diagnosis of the current tumour
Age at diagnosis
Type : Free value
Content : INTEGER
Mandatory : No
Multiple values : No
Unique : No		 Description :
Diagnosis changed
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Modification de diagnostic (diagnostic redressé) suite à la relecture anapath.<br>Exemple : en 2010 diagnostic de lipome relecture des lames en 2013 diagnostic de liposarcome le diagnostic est redressé donc Diagnosis changed = Yes.<br>Exemple : diagnostic liposarcome bien différencié qui devient après rechute un liposarcome indifférentié. Diagnosis changed = No.<br> Possible values :
No, Yes
Initial diagnosis
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Quel était le diagnostic avant que le redressement de diag ? <br> Possible values :
- Benign lesion
- Benign adipocytic tumours
- Angiolipoma
- Angiomyolipoma
- Chondroid lipoma
- Hibernoma
- Lipoblastoma/lipoblastomatosis
- Lipoma
- Lipomatosis
- Lipomatosis of nerve
- Atypical spindle cell/pleomorphic lipomatous tumour
- Myelolipoma
- Myolipoma
- Spindle cell / pleomorphic lipoma
- Benign chondrogenic tumours
- Chondroblastoma NOS
- Chondroma
- Chondromyxoid fibroma
- Enchondroma
- Osteochondroma
- Osteochondromyxoma
- Periosteal chondroma
- Pulmonary chondroma
- Pulmonary hamartoma
- Subungueal exostosis
- Synovial chondromatosis
- Benign fibroblastic/myofibroblastic tumours
- Adenofibroma
- Angiofibroma
- Angiomyofibroblastoma
- Calcifying aponeurotic fibroma
- Calcifying fibrous tumour
- Cellular angiofibroma
- Desmoplastic fibroblastoma
- Elastofibroma
- Fasciitis
- Fibroblastic tumour with SMAD3 fusion
- Fibrochondromyxoid tumour with THBS1 fusion
- Fibro-osseous pseudotumour of digits
- Fibroma of tendon sheath
- Fibromatosis colli
- Fibrous hamartoma of infancy
- Gardner fibroma
- Inclusion body fibromatosis
- Intra-nodal palisaded myofibroblastoma
- Ischaemic fasciitis
- Juvenile hyaline fibromatosis
- Myofibroblastoma
- Myositis ossificans
- Nasopharyngeal angiofibroma
- Nodular fasciitis
- Nuchal-type fibroma
- Organ-associated pseudosarcomatous myofibroblastic proliferations
- Other fibromas
- Proliferative fasciitis
- Proliferative myositis
- Benign fibro-histiocytic tumours
- Central giant cell granuloma of jaws (giant cell reparative granuloma of jaws)
- Deep benign fibrous histiocytoma
- Epithelioid fibrous histiocytoma
- Erdheim-Chester disease
- Fibrous histiocytoma
- Giant cell lesion of the small bones (extragnathic giant cell reparative granuloma)
- Langerhans cell histiocytosis
- Non Ossifying fibroma
- Rosai-Dorfman disease
- Tenosynovial giant cell tumour NOS
- Tenosynovial giant cell tumour, diffuse type
- Tenosynovial giant cell tumour, localized type
- Benign nerve sheath tumours
- Atypical neurofibromatous neoplasm of uncertain biological potential ANNUBP
- Benign Triton tumour
- Dermal nerve sheath myxoma
- Ectopic meningioma
- Granular cell tumour
- Hybrid nerve sheath tumours
- Nasal glial heterotopia
- Neurofibroma
- Neurothekeoma
- Perineurioma
- Plexiform neurofibroma
- Schwannoma
- Solitary circumscribed neuroma
- Benign notochordal tumour
- Benign osteogenic tumours
- Osteoid osteoma
- Osteoma
- Benign pericytic tumours
- Angioleiomyoma
- Glomus tumour
- Myofibroma / myofibromatosis
- Myopericytoma
- Benign skeletal muscle tumours
- Rhabdomyoma
- Rhabdomyoma - adult type
- Rhabdomyoma - fetal type
- Rhabdomyoma - genital type
- Benign smooth muscle tumours
- Atypical polypoid adenomyoma
- Adenomyoma
- Bizarre nuclei leiomyoma
- Cellular leiomyoma
- Diffuse leiomyomatosis
- Dissecans leiomyoma
- Epithelioid leiomyoma
- Intraveinous leiomyomatosis
- Leiomyoma
- Leiomyomatosis peritonealis disseminata
- Mitotically-active leiomyoma
- Myxoid leiomyoma
- Benign tumours of uncertain differentiation
- Acral fibromyxoma
- Brown tumour
- Deep (aggressive) angiomyxoma
- Ectopic hamartomatous thymoma
- Fibrous dysplasia
- Inflammatory fibroid polyp
- Intramuscular myxoma
- Myxoma NOS
- Osteofibrous dysplasia
- Pleomorphic hyalinizing angiectatic tumour
- Pleuropulmonary blastoma
- Simple bone cyst
- Superficial angiomyxoma
- Benign vascular tumours
- Angiolymphoid hyperplasia
- Angiomatosis
- Atypical vascular lesion
- Diffuse pulmonary lymphangiomatosis
- Epithelioid hemangioma
- Gorham disease
- Hemangioma
- Intra-muscular hemangioma
- Lymphangioma NOS
- Lymphangiomatosis
- Pyogenic granuloma
- Osseous pseudo-tumours
- Bizarre parosteal osteochondromatous proliferation
- Callus
- Florid ossificans periostitis
- Post-traumatic fibro-osseous lesion
- Tophaceous pseudogout
- Other benign lesion
- GIST
- gastrointestinal stromal tumour (GIST), low, very low risk
- gastrointestinal stromal tumour (GIST), intermediate risk
- gastrointestinal stromal tumour (GIST), high risk
- Non-mesenchymal malignant tumour
- Carcinoma
- Germinal tumor
- Lymphoma
- Melanoma
- Myeloma
- Other non-mesenchymal malignant tumours
- Plasmocytoma
- Other diagnoses
- Diagnosis unspecified
- Undifferentiated malignant tumour
- Sarcoma
- Chondrosarcoma
- Central chondrosarcoma
- Chondrosarcoma, grade 1
- Chondrosarcoma, grade 2
- Chondrosarcoma, grade 3
- Chondrosarcoma NOS
- Clear cell chondrosarcoma
- Dedifferentiated chondrosarcoma
- Mesenchymal chondrosarcoma
- Periosteal chondrosarcoma
- Peripheral chondrosarcoma
- Leiomyosarcoma
- Leiomyosarcoma - differentiated
- Leiomyosarcoma - epithelioid
- Leiomyosarcoma - myxoid
- Leiomyosarcoma - poorly-differentiated
- Liposarcoma
- Liposarcoma - dedifferentiated
- Liposarcoma - mixed type
- Liposarcoma - myxoid
- Liposarcoma - NOS
- Liposarcoma - pleomorphic
- Liposarcoma - round cell
- Liposarcoma - well differentiated
- Myxoid pleomorphic liposarcoma
- Malignant fibrohistiocytic tumours of bone
- Malignant giant cell tumour of bone
- Malignant peripheral nerve sheath tumour
- Ectomesenchymoma
- Malignant perineurioma
- Malignant Triton tumour
- MPNST - epithelioid type
- MPNST - usual type
- Miscellaneous sarcomas
- Alveolar soft part sarcoma
- Angiosarcoma
- BCOR sarcoma
- CIC-DUX sarcoma
- CIC-rearranged sarcoma
- Clear cell sarcoma
- Desmoplastic round cell tumour
- Epithelioid hemangioendothelioma NOS
- Epithelioid hemangioendothelioma with TFE3 fusion
- Epithelioid hemangioendothelioma with WWTR1 fusion
- Epithelioid sarcoma
- Ewing sarcoma
- Extraskeletal myxoid chondrosarcoma
- Fibrosarcoma NOS
- High risk solitary fibrous tumour
- Intimal sarcoma
- Low grade fibromyxoid sarcoma
- Low grade sinonasal sarcoma
- Malignant glomus tumour
- Malignant granular cell tumour
- Malignant mesenchymoma
- Malignant mixed tumor
- Malignant myoepithelial tumour
- Malignant ossifying fibromyxoid tumour
- Malignant PECOMA
- Malignant rhabdoid tumour
- Malignant tenosynovial giant cell tumour
- Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion
- Sclerosing epithelioid fibrosarcoma
- SMARCA4-deficient undifferentiated thoracic tumour
- Myxofibrosarcoma
- Osteosarcoma
- Conventional osteosarcoma
- Dedifferentiated low-grade central osteosarcoma
- Dedifferentiated parosteal osteosarcoma
- Extraskeletal osteosarcoma
- High-grade surface osteosarcoma
- Low-grade central osteosarcoma
- Osteoblastoma-like osteosarcoma
- Osteosarcoma NOS
- Parosteal osteosarcoma
- Periosteal osteosarcoma
- Small cell osteosarcoma
- Secondary osteosarcoma
- Telangiectasic osteosarcoma
- Other sarcomas
- Adamantinoma
- Adenosarcoma
- Chondroid chordoma
- Chordoma NOS
- Dedifferentiated adamantimoma
- Dedifferentiated chordoma
- Endometrial stromal sarcoma
- Endometrial stromal sarcoma - high-grade
- Endometrial stromal sarcoma - low-grade
- Phyllodes sarcoma
- Poorly differenciated chordoma
- Undifferentiated uterine sarcoma
- Rhabdomyosarcoma
- Adult spindle cell rhabdomyosarcoma
- Alveolar rhabdomyosarcoma
- Embryonal rhabdomyosarcoma - botryoid type
- Embryonal rhabdomyosarcoma - NOS
- Embryonal rhabdomyosarcoma - spindle cell type
- Embryonal rhabdomyosarcoma - usual type
- Pleomorphic rhabdomyosarcoma
- Rhabdomyosarcoma - NOS
- Rhabdomyosarcoma with MYOD1 mutation
- Rhabdomyosarcoma with TFCP2 fusion
- Rhabdomyosarcoma with VGLL2/NCOA2 fusion
- Sclerosing rhabdomyosarcoma
- Spindle cell rhabdomyosarcoma
- Suspicion of sarcoma
- Synovial sarcoma
- Synovial sarcoma - biphasic
- Synovial sarcoma - monophasic
- Synovial sarcoma - NOS
- Synovial sarcoma - poorly differentiated
- Undifferentiated sarcoma
- Undifferentiated epithelioid sarcoma
- Undifferentiated pleomorphic sarcoma
- Undifferentiated round cell sarcoma
- Undifferentiated sarcoma - NOS
- Undifferentiated spindle cell sarcoma
- Tumour of intermediate malignancy
- Atypical lipomatous tumour
- Intermediate chondrogenic tumours
- Atypical cartilaginous tumour
- Cartilaginous tumour of uncertain prognosis
- Chondromatosis NOS
- Intermediate fibroblastic/myofibroblastic tumours
- Dermatofibrosarcoma protuberans
- Desmoid-type fibromatosis
- Desmoplastic fibroma of bone
- Fibro-osseous tumour of bone NOS
- Fibrosarcomatous dermatofibrosarcoma protuberans
- Giant cell fibroblastoma
- Infantile fibrosarcoma
- Inflammatory myofibroblastic tumour
- Intermediate risk solitary fibrous tumour
- Lipofibromatosis
- Low grade myofibroblastic sarcoma
- Low risk solitary fibrous tumour
- Myxoinflammatory fibroblastic sarcoma
- NTRK-rearranged spindle cell neoplasm
- Palmar/plantar fibromatosis
- Superficial CD34-positive fibroblastic tumour
- Intermediate fibrohistiocytic tumours
- Giant cell tumour of bone
- Giant cell tumour of soft tissues
- Metastatic giant cell tumour of bone
- Osseous tumour rich in giant cell NOS
- Plexiform fibrohistiocytic tumour
- Suspicion of giant cell tumour of bone
- Intermediate osteogenic tumours
- Osteoblastoma NOS
- Osteogenic tumor of uncertain prognosis (osteoblastoma versus osteoblastoma-like osteosarcoma)
- Intermediate peripheral nerve sheath tumour
- Malignant melanotic neural tumour
- Intermediate tumours of uncertain differentiation
- Aneurysmal bone cyst
- Angiomatoid fibrous histiocytoma
- Atypical fibroxanthoma
- Cutaneous pleomorphic sarcoma
- Hemosiderotic fibrolipomatous tumour
- Lymphangioleiomyoma/lymphangioleiomyomatosis
- Malignant phosphaturic mesenchymal tumour
- Melanotic neuroectodermal tumour of infancy
- Mesenchymal tumor with GLI1 alteration
- Mixed tumour
- Myoepithelioma
- Ossifying fibromyxoid tumour
- PECOMA - NOS
- Phosphaturic mesenchymal tumour NOS
- Intermediate vascular tumours
- Composite hemangioendothelioma
- Epithelioid vascular tumour of bone NOS
- Kaposi sarcoma
- Kaposiform hemangioendothelioma
- Papillary intralymphatic angioendothelioma
- Pseudomyogenic hemangioendothelioma
- Retiform hemangioendothelioma
- Other tumours of intermediate malignancy
- Atypical smooth muscle tumour
- EBV-associated smooth muscle tumour (STUMP)
- Endometrial stromal nodule
- Endometrial stromal tumor low-grade
- Inflammatory rhabdomyoblastic tumour
- Metastatic leiomyoma
- Smooth muscle tumour of uncertain malignant potential (STUMP)
- Smooth muscle tumour of undetermined malignant potential (STUMP)
- Uterine tumour resembling ovarian sex cord tumours (UTROSCT)
- Other intermediate mesenchymal tumour of bone
- Mesenchymoma NOS
- Osteofibrous dysplasia-like adamantinoma
Date of review
Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No		 Description : Date à laquelle la relecture anapath a permis de redresser le diagnostic. <br>
Grade of tumour
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Histologic grade of the primary tumour according to the French grading system: tumour differentiation score 1 to 3, 0) + mitotic index (score 1 to 3, 0) + tumour necrosis (score 0 to 2, 0) Grade=1 for total score of 2 or 3 Grade=2 for total score of 4 or 5 Grade=3 for total score of 6, 7 or 8 Possible values :
1, 2, 3, NA
Mitotic Index / 50HPF
Type : Free value
Content : INTEGER
Mandatory : No
Multiple values : No
Unique : No		 Description :
Miettinen/AFIP
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Risque de malignité des GIST selon Miettinen Possible values :
Very low risk, Low risk, Intermediate risk, High risk, NA
Radiation area
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Yes : tumour developed in a previously irradiated area Possible values :
No, Yes
Lymphoedema
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Yes : tumour developed in a region with a preexisting lymphoedema Possible values :
No, Yes
Loco-regional extension
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No		 Description : Tumour invasion of healthy adjacent tissues (NB: a deep intramuscular tumour systematically invades the adjacent muscle) Possible values :
No, Dermis, Hypodermis, Vasculo-nervous, Bone, Muscle, Adjacent organ
Multifocal tumour
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : No: when tumour is only one entity Yes: when tumour is one entity associated with one or more nodules Possible values :
No, Yes
N
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Yes when there is a locoregional lymph node involvement detected by clinical and/or imaging evaluation Possible values :
No, Yes
M
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Yes when there is a distant metastasis diagnosed by imaging and / or histological evaluation Possible values :
Yes, No, Skip
StatusAtReferral
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
First event, Relapse
TTTBeforeReferral
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
No, Yes
Performance status
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : 0  Fully active, able to carry out all pre-disease performance without restriction1  (Restricted) impairment in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work2  Ambulatory and capable of all selfcare but unable to carry out any work activities for more than 50% of waking hours3  Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours4  Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair Possible values :
0, 1, 2, 3, 4, NA
Cancer status
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Cancer status at last contact Possible values :
No evidence of this cancer, Evidence of this cancer, Unknown, Not Applicable
ImagingBeforeTTT
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No		 Description : Possible values :
No, Ultrasound, CT Scan, MRI, X-Ray (standard radiograph), Other, Not available
PathoFracture
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
No, Yes
Surgery of tumour
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
No, Yes, Curettage
Date of surgery
Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No		 Description : Date of surgery
Time of surgery
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
First, Second, Third
Type of surgery of tumour
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Excision: removal of the tumour with no normal tissue at least of the surface of the tumour Wide resection: removal of the tumour with normal tissue covering all the surface of the tumour Compartimentectomy: removal of the tumour with all the tissues contained in an anatomical compartiment Amputation (of a limb or of the distal part of a limb such as a hand, foot or finger, 0) Possible values :
Excision, Wide resection, Compartimentectomy, Amputation
Surgeon
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Chirurgien qui a opéré la tumeur primaire<br>Les chirurgiens Sarcome sont listés dans Network.<br>Si la RCP propose que l'opération soit faite par un chirurgien particulier qui ne fait pas parti du réseau mais dont le nom est donné lors de la RCP il doit être saisi dans Referral to a specialized surgery outside network.<br>Si le chirurgien ne correspond pas aux situations précédentes alors saisir Outside network.<br>
Re-excision
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Reprise chirurgicale tumeur primaire<br>Ne sont prises en compte que les reprises chirurgicales ayant lieu avant la progression ou la rechute.<br><br> Possible values :
No, Yes, Curettage
Re-excision surgeon
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Chirurgien qui a ré-opéré la tumeur primaire<br>Les chirurgiens sarcome sont listés dans Network.<br>Si la RCP propose que la reprise soit faite par un chirurgien particulier qui ne fait pas parti du réseau mais dont le nom est donné lors de la RCP il doit être saisi dans Referral to a specialized surgery outside network.<br>Si le chirurgien ne correspond pas aux situations précédentes alors saisir Outside network.
Tumour spillage (CTCB)
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Expert pathologist observed if the tumour was spilt Possible values :
Yes, No
Margin R
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : R0: complete tumour resection at the macroscopic (surgeon, 0) and histological (pathologist, 0) levels R1: complete tumour resection at the macroscopic level (surgeon, 0) with tumour cells on the margins at the histological examination If the tumour is seen by the surgeon, it should be classified as R1. For most retroperitoneal tumours, the resection is R1. R2: incomplete tumour resection at the macroscopic level (surgeon, 0) Possible values :
R0, R1, R2, Not evaluable
ResidualTCells
Type : Free value
Content : PERCENTAGE
Mandatory : No
Multiple values : No
Unique : No		 Description :
BoneReconstruction
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
No, Prosthesis, Autograft, Biomaterials
ComplicationSurgery
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
No, Henderson 1, Henderson 2, Henderson 3, Henderson 4
Isolated limb perfusion
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Isolated limb perfusion Possible values :
No, Yes
DILP
Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No		 Description :
SystemicTTT
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
No, Yes
DSytTTTStart
Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No		 Description :
DSystTTTEnd
Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No		 Description :
IndicSystTTT
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
Neo-adjuvant, Adjuvant, Neo-adjuvant and adjuvant, Palliative, Not available
Radiotherapy of tumour
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : No: no radiotherapy for the primary tumour First: radiotherapy has been the first treatment performed Second: radiotherapy has been performed after another treatment such as surgery Possible values :
No, First, Second, Third, Palliative
DRTEStart
Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No		 Description :
DRTEEnd
Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No		 Description :
Dose of radiotherapy
Type : Free value
Content : DECIMAL
Mandatory : No
Multiple values : No
Unique : No		 Description : Total dose of radiotherapy given to the entity and expressed in Grays
Hormonotherapy
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Yes: when the patient was treated by hormonotherapy Possible values :
No, Yes
DHormonoTStart
Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No		 Description :
AINS
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Yes: when the patient was treated by AINS Possible values :
No, Yes
DAINSStart
Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No		 Description :
OtherTTT
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No		 Description : Possible values :
No, Radiofrequency, Cryotherapy, Embolisation, Other
Clinical trial
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Yes : when the patient has been included in a clinical trial for the treatment of the tumour Possible values :
No, Yes
Locoregional control
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Yes : no residual tumour at the primary site by clinical and imaging examinations Possible values :
Yes, No, Not available
Complete remission after treatment
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : There is no evidence of residual tumour at the end of treatment of the tumour by clinical (and imaging when performed, 0) evaluation. Possible values :
Yes, No

Local recurrence (38 items)

Rank of local recurrence
Type : Free value
Content : INTEGER
Mandatory : Yes
Multiple values : No
Unique : No		 Description : Rank of local recurrence
Date of local recurrence
Type : Free value
Content : DATE
Mandatory : Yes
Multiple values : No
Unique : No		 Description : Date of diagnosis of the first local recurrence
Size of tumour (mm)
Type : Free value
Content : INTEGER
Mandatory : No
Multiple values : No
Unique : No		 Description : Largest diameter of the tumour expressed in mm
Depth of tumour
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Superficial: the tumour is located above the superficial aponeurosis with no involvement of this aponeurosis Deep: the tumour is located beneath the superficial aponeurosis with no involvement of the area above this aponeurosis. Involvement of the aponeurosis is possibleSuperficial and deep: the tumour is located above and beneath the superficial aponeurosis Possible values :
Superficial, Superficial and deep, Deep, Surface, Cortical, Intra-medullary
Multifocal tumour
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : No: when tumour is only one entity Yes: when tumour is one entity associated with one or more nodules Possible values :
No, Yes
Radiation area
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Yes : tumour developed in a previously irradiated area Possible values :
No, Yes
Performance status
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : 0  Fully active, able to carry out all pre-disease performance without restriction1  (Restricted) impairment in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work2  Ambulatory and capable of all selfcare but unable to carry out any work activities for more than 50% of waking hours3  Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours4  Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair Possible values :
0, 1, 2, 3, 4, NA
PathoFracture
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
No, Yes
Surgery of tumour
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
No, Yes, Curettage
Date of surgery
Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No		 Description : Date of surgery
Time of surgery
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
First, Second, Third
Type of surgery of tumour
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Excision: removal of the tumour with no normal tissue at least of the surface of the tumour Wide resection: removal of the tumour with normal tissue covering all the surface of the tumour Compartimentectomy: removal of the tumour with all the tissues contained in an anatomical compartiment Amputation (of a limb or of the distal part of a limb such as a hand, foot or finger, 0) Possible values :
Excision, Wide resection, Compartimentectomy, Amputation
SurgeonLR
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
Network, Outside Network
Re-excision
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Reprise chirurgicale tumeur primaire<br>Ne sont prises en compte que les reprises chirurgicales ayant lieu avant la progression ou la rechute.<br><br> Possible values :
No, Yes, Curettage
ReExcisionSurgeonLR
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
Network, Outside Network
Tumour spillage (CTCB)
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Expert pathologist observed if the tumour was spilt Possible values :
Yes, No
Margin R
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : R0: complete tumour resection at the macroscopic (surgeon, 0) and histological (pathologist, 0) levels R1: complete tumour resection at the macroscopic level (surgeon, 0) with tumour cells on the margins at the histological examination If the tumour is seen by the surgeon, it should be classified as R1. For most retroperitoneal tumours, the resection is R1. R2: incomplete tumour resection at the macroscopic level (surgeon, 0) Possible values :
R0, R1, R2, Not evaluable
ResidualTCells
Type : Free value
Content : PERCENTAGE
Mandatory : No
Multiple values : No
Unique : No		 Description :
BoneReconstruction
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
No, Prosthesis, Autograft, Biomaterials
ComplicationSurgery
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
No, Henderson 1, Henderson 2, Henderson 3, Henderson 4
SystemicTTT
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
No, Yes
DSytTTTStart
Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No		 Description :
DSystTTTEnd
Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No		 Description :
IndicSystTTT
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
Neo-adjuvant, Adjuvant, Neo-adjuvant and adjuvant, Palliative, Not available
Isolated limb perfusion
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Isolated limb perfusion Possible values :
No, Yes
DILP
Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No		 Description :
Radiotherapy of tumour
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : No: no radiotherapy for the primary tumour First: radiotherapy has been the first treatment performed Second: radiotherapy has been performed after another treatment such as surgery Possible values :
No, First, Second, Third, Palliative
DRTEStart
Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No		 Description :
DRTEEnd
Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No		 Description :
Dose of radiotherapy
Type : Free value
Content : DECIMAL
Mandatory : No
Multiple values : No
Unique : No		 Description : Total dose of radiotherapy given to the entity and expressed in Grays
Hormonotherapy
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Yes: when the patient was treated by hormonotherapy Possible values :
No, Yes
DHormonoTStart
Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No		 Description :
AINS
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Yes: when the patient was treated by AINS Possible values :
No, Yes
DAINSStart
Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No		 Description :
Clinical trial
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Yes : when the patient has been included in a clinical trial for the treatment of the tumour Possible values :
No, Yes
OtherTTT
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No		 Description : Possible values :
No, Radiofrequency, Cryotherapy, Embolisation, Other
Locoregional control
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Yes : no residual tumour at the primary site by clinical and imaging examinations Possible values :
Yes, No, Not available
Complete remission after treatment
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : There is no evidence of residual tumour at the end of treatment of the tumour by clinical (and imaging when performed, 0) evaluation. Possible values :
Yes, No

Metastatic disease (8 items)

Location of first metastasis
Type : Constrained
Content : TEXT
Mandatory : Yes
Multiple values : Yes
Unique : No		 Description : Location of first metastasis Possible values :
Bone, Bone marrow, Brain, Liver, Lung, Lymph node, Peritoneum, Pleura, Skin, Soft tissues, Other
Date of first metastasis
Type : Free value
Content : DATE
Mandatory : Yes
Multiple values : No
Unique : No		 Description : Date of diagnosis of the first metastasis
Number of metastatic sites
Type : Free value
Content : INTEGER
Mandatory : No
Multiple values : No
Unique : No		 Description : Number of metastasic sites at diagnosis
Location of further metastasis
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No		 Description : Location of further metastasis Possible values :
Bone, Bone marrow, Brain, Liver, Lung, Lymph node, Peritoneum, Pleura, Skin, Soft tissues, Other, No
TTTM
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No		 Description : Possible values :
No, Systemic treatment, Locoregional treatment, AINS, Other
Locoregional treatment of metastasis
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No		 Description : Choose one or several (CTRL + clic) type(s) of locoregional treatment for the treatment of metastasis Possible values :
Surgery, Radiofrequency, Cryotherapy, Radiotherapy, Other
IndicSystTTT
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
Neo-adjuvant, Adjuvant, Neo-adjuvant and adjuvant, Palliative, Not available
Clinical trial
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Yes : when the patient has been included in a clinical trial for the treatment of the tumour Possible values :
No, Yes

Sample (18 items)

Sample reference
Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : Yes		 Description : The sample reference in the center
Date of sampling
Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No		 Description : Date on which the sample was removed
Metastasis sample location
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Location of this metastasis sample (only for metastasis sample) Possible values :
Bone, Bone marrow, Brain, Liver, Lung, Lymph node, Peritoneum, Pleura, Skin, Soft tissues, Other
Treatment before sampling
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No		 Description : No : no treatment of the tumour event before sampling Chemotherapy: the tumour event has been received a chemotherapy before sampling Radiotherapy: radiotherapy on the tumour event before sampling ILP: an isolated limb perfusion procedure has been performed on the tumour event before sampling Other: other treatment has been performed on the tumour event before sampling Possible values :
No, Systemic treatment, Radiotherapy, ILP, Other
Type of sampling
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Microbiopsy: sampling of the tumour with a core needleOpen biopsy: surgical resection of a piece of the tumour with a diagnostic intendTumour resection: surgical resection of the whole tumour Possible values :
Microbiopsy, Open biopsy, Tumour resection, Curettage
Immunohistochemistry
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
No, Yes
FISH
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
No, Yes
Result FISH
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
In progress, Negative, Non interpretable, Positive
Molecular Biology
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Molecular Biology techniques performed Possible values :
No, Yes
Result (Molecular Biology)
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
In progress, Negative, Positive, Non interpretable
RNASeq
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
Not done, Done non interpretable, Done interpretable
Gene 1
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Fusion transcript gene 1 Possible values :
No transcrit, Other, A2M, ABHD12B, AC011523.2, ACBD5, ACSL3, ACSL5, ACTB, ACTN1, ADGRF5, AFAP1, AFF3, AGBL4, AGK, AGTRAP, AHCYL1, AHRR, AKAP13, AKAP9, AKT3, ALK, AMACR, AP3S1, APIP, ARHGAP12, ARID1A, ARID1B, ASPSCR1, ATF1, ATG16L1, ATIC, ATP11B, ATP2B4, ATXN1, AUTS2, BAG4, BAIAP2L1, BCAN, BCAP29, BCL10, BCL2, BCLAF1, BCOR, BCORL1, BCR, BICC1, BIRC3, BMX, BRAF, BRD1, BRD3, BRD4, BRD8, BTBD1, C11orf95, C19MC, C3orf62, C5orf30, CAB39L, CAD, CALML4, CAMTA1, CANT1, CAPZA2, CARMN, CARS, CASP7, CCAR2, CCDC6, CCDC67, CCDC88C, CCNB3, CCND1, CCNH, CD101, CD44, CD63, CD74, CD99L2, CDC27, CDH11, CDH17, CDK5RAP2, CDX1, CEACAM5, CEP128, CEP192, CEP89, CHCHD7, CHD7, CIC, CIITA, CITED1, CITED2, CLCN6, CLDN1, CLIP1, CLIP2, CLN6, CLTC, CNNM3, COL12A1, COL17A1, COL1A, COL1A1, COL1A2, COL3A1, COL6A3, COMMD10, CPG, CPSF6, CREB1, CREB3L1, CREB3L2, CREB3L3, CREBBP, CREBZF, CREM, CRTC1, CRTC3, CSF1, CTB.35F21.1, CTNNA3, CTNNB1, CXCR4, CXorf67, DACH1, DAXX, DCTN1, DDIT3, DDX3X, DDX5, DIP2C, DKKL1, DNAH5, DNAJB6, DST, DTD1, DUS4L, DUX4, DUX4L2, E2F1, EEF1AKMT3, EGF, EGFR, EHBP1, EIF3E, ELF5, ELK4, ELN, EMILIN2, EML4, EMP1, EP300, EP400, EPC1, EPC2, EPS15, ERBB2, ERC1, ERG, ERLIN2, ESR1, ESRP1, EST14, ETV1, ETV2, ETV4, ETV5, ETV6, EWSR1, EZR, FAM131B, FAM227A, FER, FEV, FGF1, FGF2, FGFR1, FGFR2, FGFR3, FHIT, FIP1L1, FLI1, FLJ60017, FN1, FOSB, FOXO1, FOXO4, FOXO6, FOXP1, FOXR1, FUS, GCC2, GCNT3, GIT2, GLI1, GNAI1, GOLGA5, GOLGB1, GOPC, GPN1, GPS2, GREB1, GRIK2, GRM1, GSN, GTF2I, GTF3C2, GUCA2B, HAS2, HBA, HBA2, HBB, HENMT1, HERV-K, HERVK17, HEY1, HIP1, HIPK1, HLA-A, HMGA1, HMGA2, HMGN2P46, HNRNPA2B1, HOOK1, HOOK3, HOXD13, HS6ST2, HSPA8, HTN3, HTT, IG, IGF2, IGFBP5, IGH, IGK, IGL, IKBKG, INO80D, IRF2BP2, IRF4/DUSP22, ITD, JAK2, JAZF1, KANSL1, KAT6B, KCTD7, KDM2A, KDM2B, KDM4B, KHDRB52, KHSRP, KIAA1217, KIAA1549, KIAA1598, KIF5B, KIFC3, KIRREL, KLC1, KLF15, KLF17, KLHL29, KLHL7, KLK2, KMT2A, KRAS, KTN1, LACTB2, LAMTOR1, LIFR, LMAN2L, LMNA, LPP, LRIG3, LRRC31, LRRC34, LRRC59, LRRFIP1, LRRFIP2, LSM14A, LUC7L3, LYN, MAD1L1, MAGI3, MALAT1, MALT1, MAML2, MAML3, MAN2A1, MAP3K8, MBD1, MBTD1, MDK, MEAF6, MECOM, MED12, MEF2C, MEIS1, MELK, MET, MGA, MIPOL1, MIR143HG, MITF, MKL2, MKRN1, MLL, MLL4, MLPH, MPRIP, MSANTD3, MSN, MTOR, MXD1, MYB, MYBL1, MYC, MYH10, MYH9, MYO5A, NAB2, NACC2, NAV2, NCOA1, NCOA2, NCOA3, NCOA4, NCOR2, ND4, NDRG1, NF1, NFASC, NFATC1, NFATC2, NFIA, NFIB, NOL4L, NONO, NOS2, NOTCH1, NOTCH2, NOTCH3, NPC1, NPM1, NR4A3, NRG1, NSD3, NTRK1, NTRK2, NTRK3, NUDCD3, NUMA1, NUP160, NUP214, NUP98, NUTM1, NUTM2A, NUTM2B, NUTM2E, OFD1, OGDH, OMD, PAFAH1B2, PAN3, PAPSS1, PARP14, PATZ1, PAX3, PAX5, PAX7, PAX8, PBX1, PBX3, PDCD1LG2, PDE3B, PDE4DIP, PDE8A, PDGFB, PDGFD, PDGFRA, PDGFRB, PDHX, PDPN, PHF1, PIK3C2A, PITPNC1, PLA2G6, PLAG1, PLIN3, PML, POM121, POU1F1, POU3F1, POU5F1, PPAPDC1A, PPARG, PPFIBP1, PPL, PPP1R1B, PPP6R3, PRB3, PRCC, PRDM10, PRG4, PRKAR1A, PRKCA, PRKCB, PRKCD, PRKD1, PRKDC, PRKG1, PSD2, PSMA8, PTCH1, PTEN, PTMA, PTPRD, PTPRJ, PTPRK, PTPRZ1, PVT1, PWWP2A, QKI, RAB2A, RABGAP1L, RAD51, RAD51B, RAD52, RAF1, RANBP2, RARG, RBM10, RCC1, RELA, RET, RFWD2, RNF13, RNF130, RNF213, ROS1, RP11.57H14.3, RPLP1, RPS11, RRBP1, RREB1, RSPO2, RSPO3, RUNX1, S100A10, SCARB1, SCYL3, SDC4, SEC31A, SEC61G, SERINC1, SERPINE1, SET, SETBP1, SFMBT1, SFPQ, SHH, SLC11A2, SLC12A7, SLC16A7, SLC1A2, SLC26A11, SLC34A2, SLC3A2, SLC43A3, SLC45A2, SLC45A3, SLC5A11, SLC7A14, SMAD2, SMAD3, SMARCA4, SMARCA5, SNAPC3, SND1, SNX19, SOS1, SOX6, SP3, SPATA16, SPECC1L, SPTBN1, SQSTM1, SRF, SS18, SS18L1, SSX1, SSX2, SSX2B, SSX4, STARD3, STAT6, STK32B, STRN, SUZ12, SVIL, TACC1, TACC3, TAF15, TAX1BP1, TBL1XR1, TCEA1, TCF12, TCF4, TCF7L2, TEAD1, TENM4, TERT, TFCP2, TFE3, TFEB, TFG, TGFBR3, THBS1, THRAP3, TIMP3, TLN2, TMEM135, TMPRSS2, TNC, TNS3, TOM1L2, TOP2B, TP53, TP53BP1, TPM1, TPM3, TPM4, TPR, TPRG1, TPTEP1, TRA2B, TRIM11, TRIM24, TRIM27, TRIM33, TRIM4, TRIO, TRIT1, TRMT11, TSFM, TTC17, TTC28, TTYH1, UBE2L3, UBR5, ULK4, USP6, VCL, VGLL2, VGLL3, VGLL4, VIM, VMP1, VTI1A, WDR91, WHSC1L1, WIF1, WT1, WWTR1, YAP1, YWHAE, YY1, ZC3H7B, ZCCHC8, ZFP36, ZFPM2, ZKSCAN1, ZKSCAN5, ZMYM2, ZNF207, ZNF217, ZNF278, ZNF423, ZNF444, ZNF521, ZNF595, ZNF737, ZNF9
Unlisted gene 1
Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Fusion transcript unlisted gene 1
Gene 2
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Fusion transcript gene 2 Possible values :
No transcrit, Other, A2M, ABHD12B, AC011523.2, ACBD5, ACSL3, ACSL5, ACTB, ACTN1, ADGRF5, AFAP1, AFF3, AGBL4, AGK, AGTRAP, AHCYL1, AHRR, AKAP13, AKAP9, AKT3, ALK, AMACR, AP3S1, APIP, ARHGAP12, ARID1A, ARID1B, ASPSCR1, ATF1, ATG16L1, ATIC, ATP11B, ATP2B4, ATXN1, AUTS2, BAG4, BAIAP2L1, BCAN, BCAP29, BCL10, BCL2, BCLAF1, BCOR, BCORL1, BCR, BICC1, BIRC3, BMX, BRAF, BRD1, BRD3, BRD4, BRD8, BTBD1, C11orf95, C19MC, C3orf62, C5orf30, CAB39L, CAD, CALML4, CAMTA1, CANT1, CAPZA2, CARMN, CARS, CASP7, CCAR2, CCDC6, CCDC67, CCDC88C, CCNB3, CCND1, CCNH, CD101, CD44, CD63, CD74, CD99L2, CDC27, CDH11, CDH17, CDK5RAP2, CDX1, CEACAM5, CEP128, CEP192, CEP89, CHCHD7, CHD7, CIC, CIITA, CITED1, CITED2, CLCN6, CLDN1, CLIP1, CLIP2, CLN6, CLTC, CNNM3, COL12A1, COL17A1, COL1A, COL1A1, COL1A2, COL3A1, COL6A3, COMMD10, CPG, CPSF6, CREB1, CREB3L1, CREB3L2, CREB3L3, CREBBP, CREBZF, CREM, CRTC1, CRTC3, CSF1, CTB.35F21.1, CTNNA3, CTNNB1, CXCR4, CXorf67, DACH1, DAXX, DCTN1, DDIT3, DDX3X, DDX5, DIP2C, DKKL1, DNAH5, DNAJB6, DST, DTD1, DUS4L, DUX4, DUX4L2, E2F1, EEF1AKMT3, EGF, EGFR, EHBP1, EIF3E, ELF5, ELK4, ELN, EMILIN2, EML4, EMP1, EP300, EP400, EPC1, EPC2, EPS15, ERBB2, ERC1, ERG, ERLIN2, ESR1, ESRP1, EST14, ETV1, ETV2, ETV4, ETV5, ETV6, EWSR1, EZR, FAM131B, FAM227A, FER, FEV, FGF1, FGF2, FGFR1, FGFR2, FGFR3, FHIT, FIP1L1, FLI1, FLJ60017, FN1, FOSB, FOXO1, FOXO4, FOXO6, FOXP1, FOXR1, FUS, GCC2, GCNT3, GIT2, GLI1, GNAI1, GOLGA5, GOLGB1, GOPC, GPN1, GPS2, GREB1, GRIK2, GRM1, GSN, GTF2I, GTF3C2, GUCA2B, HAS2, HBA, HBA2, HBB, HENMT1, HERV-K, HERVK17, HEY1, HIP1, HIPK1, HLA-A, HMGA1, HMGA2, HMGN2P46, HNRNPA2B1, HOOK1, HOOK3, HOXD13, HS6ST2, HSPA8, HTN3, HTT, IG, IGF2, IGFBP5, IGH, IGK, IGL, IKBKG, INO80D, IRF2BP2, IRF4/DUSP22, ITD, JAK2, JAZF1, KANSL1, KAT6B, KCTD7, KDM2A, KDM2B, KDM4B, KHDRB52, KHSRP, KIAA1217, KIAA1549, KIAA1598, KIF5B, KIFC3, KIRREL, KLC1, KLF15, KLF17, KLHL29, KLHL7, KLK2, KMT2A, KRAS, KTN1, LACTB2, LAMTOR1, LIFR, LMAN2L, LMNA, LPP, LRIG3, LRRC31, LRRC34, LRRC59, LRRFIP1, LRRFIP2, LSM14A, LUC7L3, LYN, MAD1L1, MAGI3, MALAT1, MALT1, MAML2, MAML3, MAN2A1, MAP3K8, MBD1, MBTD1, MDK, MEAF6, MECOM, MED12, MEF2C, MEIS1, MELK, MET, MGA, MIPOL1, MIR143HG, MITF, MKL2, MKRN1, MLL, MLL4, MLPH, MPRIP, MSANTD3, MSN, MTOR, MXD1, MYB, MYBL1, MYC, MYH10, MYH9, MYO5A, NAB2, NACC2, NAV2, NCOA1, NCOA2, NCOA3, NCOA4, NCOR2, ND4, NDRG1, NF1, NFASC, NFATC1, NFATC2, NFIA, NFIB, NOL4L, NONO, NOS2, NOTCH1, NOTCH2, NOTCH3, NPC1, NPM1, NR4A3, NRG1, NSD3, NTRK1, NTRK2, NTRK3, NUDCD3, NUMA1, NUP160, NUP214, NUP98, NUTM1, NUTM2A, NUTM2B, NUTM2E, OFD1, OGDH, OMD, PAFAH1B2, PAN3, PAPSS1, PARP14, PATZ1, PAX3, PAX5, PAX7, PAX8, PBX1, PBX3, PDCD1LG2, PDE3B, PDE4DIP, PDE8A, PDGFB, PDGFD, PDGFRA, PDGFRB, PDHX, PDPN, PHF1, PIK3C2A, PITPNC1, PLA2G6, PLAG1, PLIN3, PML, POM121, POU1F1, POU3F1, POU5F1, PPAPDC1A, PPARG, PPFIBP1, PPL, PPP1R1B, PPP6R3, PRB3, PRCC, PRDM10, PRG4, PRKAR1A, PRKCA, PRKCB, PRKCD, PRKD1, PRKDC, PRKG1, PSD2, PSMA8, PTCH1, PTEN, PTMA, PTPRD, PTPRJ, PTPRK, PTPRZ1, PVT1, PWWP2A, QKI, RAB2A, RABGAP1L, RAD51, RAD51B, RAD52, RAF1, RANBP2, RARG, RBM10, RCC1, RELA, RET, RFWD2, RNF13, RNF130, RNF213, ROS1, RP11.57H14.3, RPLP1, RPS11, RRBP1, RREB1, RSPO2, RSPO3, RUNX1, S100A10, SCARB1, SCYL3, SDC4, SEC31A, SEC61G, SERINC1, SERPINE1, SET, SETBP1, SFMBT1, SFPQ, SHH, SLC11A2, SLC12A7, SLC16A7, SLC1A2, SLC26A11, SLC34A2, SLC3A2, SLC43A3, SLC45A2, SLC45A3, SLC5A11, SLC7A14, SMAD2, SMAD3, SMARCA4, SMARCA5, SNAPC3, SND1, SNX19, SOS1, SOX6, SP3, SPATA16, SPECC1L, SPTBN1, SQSTM1, SRF, SS18, SS18L1, SSX1, SSX2, SSX2B, SSX4, STARD3, STAT6, STK32B, STRN, SUZ12, SVIL, TACC1, TACC3, TAF15, TAX1BP1, TBL1XR1, TCEA1, TCF12, TCF4, TCF7L2, TEAD1, TENM4, TERT, TFCP2, TFE3, TFEB, TFG, TGFBR3, THBS1, THRAP3, TIMP3, TLN2, TMEM135, TMPRSS2, TNC, TNS3, TOM1L2, TOP2B, TP53, TP53BP1, TPM1, TPM3, TPM4, TPR, TPRG1, TPTEP1, TRA2B, TRIM11, TRIM24, TRIM27, TRIM33, TRIM4, TRIO, TRIT1, TRMT11, TSFM, TTC17, TTC28, TTYH1, UBE2L3, UBR5, ULK4, USP6, VCL, VGLL2, VGLL3, VGLL4, VIM, VMP1, VTI1A, WDR91, WHSC1L1, WIF1, WT1, WWTR1, YAP1, YWHAE, YY1, ZC3H7B, ZCCHC8, ZFP36, ZFPM2, ZKSCAN1, ZKSCAN5, ZMYM2, ZNF207, ZNF217, ZNF278, ZNF423, ZNF444, ZNF521, ZNF595, ZNF737, ZNF9
Unlisted gene 2
Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Fusion transcript unlisted gene 2
Frozen tissue
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
No, Yes
Paraffin available
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
No, Yes
Virtual slide
Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description :

Paraffin (8 items)

Number of paraffin blocks with tumour
Type : Free value
Content : INTEGER
Mandatory : No
Multiple values : No
Unique : No		 Description : Number of paraffin blocks with tumour available in your Centre
TMA
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Yes: if sample of paraffin block is included in a TMA (Tissue Micro Array) Possible values :
No, Yes
Storage centre
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Centre where TMA is stored Possible values :
ANGERS, ARTTIC, BERGONIE, BRUXELLES, CAEN, CCRC, CLERMONT-FERRAND, Cochin, CURIE, DIJON, ERASM, HENRI MONDOR, ICR, IGR, INT, IPSO, KLEUVEN, LAUSANNE, LBPA, LCC, LILLE, MARSEILLE CHU, MARSEILLE IPC, MAUNIHEI, MONTPELLIER, NANCY, NANTES, NICE, P-MAR, Paris Ouest, Rennes, SAINT-CLOUD, SANAV, SLS, STRASBOURG, TOULOUSE, UCBL, UNIPD, Warsaw Cancer Center, Bonn University
Array-CGH
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Yes: array-CGH done Possible values :
Not done, Done non interpretable, Done interpretable
Genomic index
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Value of genomic index Possible values :
GI1, GI2
ExomeSeq
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
Not done, Done non interpretable, Done interpretable
MethylSeq
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
Not done, Done non interpretable, Done interpretable
Web review
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Yes : if the case has been reviewed using virtual slide Possible values :
No, Yes

Frozen tissue (16 items)

Storage temperature
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Storage temperature of the frozen material according to the scroll menu Possible values :
-80°C, -140°C, Liquid nitrogen
Availability of tissue sample
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Available: frozen material has not been used and is available in the local Center In use: frozen material is currently in use in one or several studies Terminated: there is no frozen material left but nucleic acids (DNA and/or RNA, 0) may be still available Possible values :
Terminated, In use, Available
Number of tubes
Type : Free value
Content : INTEGER
Mandatory : No
Multiple values : No
Unique : No		 Description : Number of tubes containing  tumour fragments stored
Specific translocation
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Yes: karyotype showes a translocation Possible values :
t(X;17)(p11;q25) (Alveolar soft part sarcoma), t(9;22)(q22;q12) (Extraskeletal myxoid chondrosarcoma), t(9;17)(q22;q11) (Extraskeletal myxoid chondrosarcoma), t(9;15)(q22;q21) (Extraskeletal myxoid chondrosarcoma), t(12;22)(q13;q12) (Clear cell sarcoma), t(11;22)(p13;q12) (Desmoplastic small round cell tumor), t(17;22)(q21;q13) (Dermatofibrosarcoma protuberans), t(11;22)(q24;q12) (Ewing?s sarcoma/Primitive neuroectodermal tumor), t(21;22)(q22;q12) (Ewing?s sarcoma/Primitive neuroectodermal tumor), t(7;22)(p22;q12) (Ewing?s sarcoma/Primitive neuroectodermal tumor), t(17;22)(q12;q12) (Ewing?s sarcoma/Primitive neuroectodermal tumor), t(2;22)(q33;q12) (Ewing?s sarcoma/Primitive neuroectodermal tumor), t(1;16)(q21;q13) (Ewing?s sarcoma/Primitive neuroectodermal tumor), t(12;16)(q13;p11) (Liposarcoma, myxoid/round cell), t(12;22)(q13;q12) (Liposarcoma, myxoid/round cell), t(2;13)(q35;q14) (Alveolar rhabdomyosarcoma), t(1;13)(p36;q14) (Alveolar rhabdomyosarcoma), t(X;18)(p11;q11) (Synovial sarcoma)
Array-CGH
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Yes: array-CGH done Possible values :
Not done, Done non interpretable, Done interpretable
Genomic index
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Value of genomic index Possible values :
GI1, GI2
RNA expression profile
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Yes: expression profile done Possible values :
Not done, Done non interpretable, Done interpretable
CINSARC
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Value of CINSARC Possible values :
C1, C2
SNP analysis
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Yes: SNP analysis done Possible values :
Not done, Done non interpretable, Done interpretable
miRNA analysis
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Yes: miRNA analysis done Possible values :
Not done, Done non interpretable, Done interpretable
ExomeSeq
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
Not done, Done non interpretable, Done interpretable
MethylSeq
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
Not done, Done non interpretable, Done interpretable
Whole Genome Sequencing
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
Not done, Done non interpretable, Done interpretable
Karyotyping
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Yes: karyotype done Possible values :
Not done, Done
Vamp ID
Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description :
Weight of frozen tissue
Type : Free value
Content : INTEGER
Mandatory : No
Multiple values : No
Unique : No		 Description : Total weigh of frozen tumours fragments in mg

Cell line (11 items)

Cell line reference
Type : Free value
Content : TEXT
Mandatory : Yes
Multiple values : No
Unique : Yes		 Description : <span style="font-size: 13.3333px;">The cell line reference in the center</span>
Number of passages
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Number of passages after put in culture of cells Possible values :
-30, +30
Dilution
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Dilution done at each passage Possible values :
1/2, 1/4, 1/8, 1/10
Passage frequency
Type : Free value
Content : INTEGER
Mandatory : No
Multiple values : No
Unique : No		 Description : Number of days between 2 passages
Molecular validation
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Method to check cells are tumorous by chromosome spreading, FISH or sequencing Possible values :
Yes, No, Not available
Array-CGH
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Yes: array-CGH done Possible values :
Not done, Done non interpretable, Done interpretable
Genomic index
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Value of genomic index Possible values :
GI1, GI2
RNA expression profile
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Yes: expression profile done Possible values :
Not done, Done non interpretable, Done interpretable
CINSARC
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Value of CINSARC Possible values :
C1, C2
miRNA analysis
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Yes: miRNA analysis done Possible values :
Not done, Done non interpretable, Done interpretable
MultiFISH
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Yes: multiFISH done Possible values :
not done, done interpretable, not interpretable

Blood sample (7 items)

Sample reference
Type : Free value
Content : TEXT
Mandatory : Yes
Multiple values : No
Unique : Yes		 Description : The sample reference in the center
Date of sampling
Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No		 Description : Date on which the sample was removed
Treatment before sampling
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No		 Description : No : no treatment of the tumour event before sampling Chemotherapy: the tumour event has been received a chemotherapy before sampling Radiotherapy: radiotherapy on the tumour event before sampling ILP: an isolated limb perfusion procedure has been performed on the tumour event before sampling Other: other treatment has been performed on the tumour event before sampling Possible values :
No, Systemic treatment, Radiotherapy, ILP, Other
Type of material
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Type of material stored Possible values :
Serum, Plasma, Lymphocytes, Total blood
Consent
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Yes: consent obtained from the patient Possible values :
Yes, No, NA
Storage centre
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Centre where TMA is stored Possible values :
ANGERS, ARTTIC, BERGONIE, BRUXELLES, CAEN, CCRC, CLERMONT-FERRAND, Cochin, CURIE, DIJON, ERASM, HENRI MONDOR, ICR, IGR, INT, IPSO, KLEUVEN, LAUSANNE, LBPA, LCC, LILLE, MARSEILLE CHU, MARSEILLE IPC, MAUNIHEI, MONTPELLIER, NANCY, NANTES, NICE, P-MAR, Paris Ouest, Rennes, SAINT-CLOUD, SANAV, SLS, STRASBOURG, TOULOUSE, UCBL, UNIPD, Warsaw Cancer Center, Bonn University
Whole Genome Sequencing
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
Not done, Done non interpretable, Done interpretable

Chemotherapy line (11 items)

Rank of Chemotherapy line
Type : Free value
Content : INTEGER
Mandatory : No
Multiple values : No
Unique : No		 Description : Rank of Chemotherapy line
Date of first cycle
Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No		 Description : Date start of cycle of chemotherapy
DateEndCycle
Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No		 Description :
Performance status
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : 0  Fully active, able to carry out all pre-disease performance without restriction1  (Restricted) impairment in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work2  Ambulatory and capable of all selfcare but unable to carry out any work activities for more than 50% of waking hours3  Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours4  Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair Possible values :
0, 1, 2, 3, 4, NA
Drugs
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No		 Description : Possible values :
90Y-Ibritumomab tiuxetan, Abraxane, Abemaciclib, ADEPT, AINS, Aldesleukin, Aldoxorubicin, Alectinib, Alemtuzumab, AMG 706, Amsacrine, Atezolizumab, Avapritinib, Avelumab, Azacitidine, Bendamustine, Bevacizumab, Bezuclastinib/CGT9486, BI2536, Binimetinib, BKM120 - Buparlisib, Bleomycin, Bortezomib, Brostallicin, Busulfan, Cabazitaxel, Capecitabine, Carboplatin, Cabozantinib, Carmustine, Ceritinib, Cetuximab, Chlorambucil, Cisplatin, Cixutumumab, Cladribine, Clofarabine, Cobimetinib, Conatumumab, Crenigacestat, Crenolanib, Crisantaspase, Crizotinib, Cyclophosphamide, Cytarabine, Dabrafenib, Dacarbazine, Dactinomycin, Dalotuzumab, Dasatinib, Daunorubicin, DCC-2618, Deforolimus, Denosumab, Docetaxel, Dovitinib, Doxorubicin, Durvalumab, Emactuzumab, Encorafenib, Entrectinib, Epirubicin, Eribulin, Erlotinib, Etoposide, Everolimus, Evofosfamide, Farmorubicine, FDH, Fludarabine, Fluorouracil, Fotemustin, FPA0008, Fulvestrant, Gefitinib, Gemcitabine, Gemtuzumab, Gimatecan, Gliadel implants, Halichondrin B, HDM201, Hormonotherapy, Hydroxycarbamide, Idarubicin, IDRX-42, Ifosfamide, Imatinib, Interferon alpha, Interleukin-2, Iodine-131 tositumomab, Ipilimumab, Irinotecan, JX-594(Pexa-vec), Lapatinib, Larotrectinib, Lenalidomide, Lenvatinib, Leucovorin, Liposomal daunorubicin, Liposomal doxorubicin, Lomustine, Lornatinib, Masitinib, Melphalan, Mercaptopurine, Mesna, Methotrexate, Mitomycin, Mitotane, Mitoxantrone, Motesanib, NB003, NBTXR3, NGR-hTNF, Nilotinib, Nintedanib, Nivolumab, NVL-655, Olaparib, Olaratumab, Ombrabulin, Ontuxizumab (MORAb-004), Oxaliplatin, Paclitaxel, Palbociclib, Palifosfamide, Panitumumab, Panobinostat, Pazopanib, Pembrolizumab, Pemetrexed, Pentostatin, Pexidartinib, Placebo, Ponatinib, Prednisolone, Procarbazine, R1507 (Teprotumumab), Raltitrexed, Ramucirumab, Rasburicase, Regorafenib, Relatlimab, Ribociclib, Ridaforolimus, Ripretinib, Rituximab, RO5045337 / RG7112 (Nutlin), S9788, Satraplatin, Selpercatinib, Siremadlin (HDM201), Sirolimus, Sorafenib, Streptozocin, Sunitinib, Tamoxifen, Tasonermine, Tazemetostat, Tegafur-uracil, Temozolomide, Temsirolimus, Tenoposide, Thalidomide, Thiotepa, Tioguanine, Topotecan, Trabectedin, Trametinib, Trastuzumab, Tremelimumab, Treosulfan, Vinblastine, Vemurafenib, Vincristine, Vindesine, Vinorelbine, Vismodegib, Vistusertib, Warfarin, Other
Clinical trial
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Yes : when the patient has been included in a clinical trial for the treatment of the tumour Possible values :
No, Yes
Clinical trial name
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Clinical trial name according to the scroll menu Possible values :
Clinical trial name to complete, 105SAR301 TAPPAS, 20140114, AB04030, AB07001, AB1010, AB11002, AcSé Crizotinib, ACSE Pembrolizumab, Acsé-eSMART-CSET, ADP-0044-002 - SPEARHEAD 1, ALDOXORUBICIN, ALTGIST, AGADIR, AMG706, AMGEN 20060324, ANGIO-NEXT, ANGIOTAX, ANGIOTAX-PLUS, ANNOUNCE 1, ARO-012 CRENOGIST, ASCEND10, ATEZOGIST, BAY734506, BET115521, BFR14, BKM120, BLU-285-1101, BLU-285-1303 , BO20924, BP27772, BP29428, BROSTALLICINE, CA017-003, CA209-848, CABOGIST, CABONE, CAIRE, CAMN107, CGM097, CHDM201X2103C, CHONDROG, CHONRAD, CISTEM, COMBINAIR 3, CONGRATS, CRAD001C2206, CRAD001X2109, CREATE, CSTI571X2103, CYCLIGIST, DCC2618-03-002 : INTRIGUE, DCC2618-23-001 : INTRIGUE , DESMOPAZ, DOVIGIST, E7389-G000-213, E7438-G000-101, EFC 10145, EISAI E7389, EORTC-1202, EORTC-1403-REECUR, EORTC-1447-STBSG, EORTC-1506-STBSG-ANITA, EORTC-62005, EORTC-62012, EORTC-62022-IRESSA , EORTC-62024, EORTC-62043, EORTC-62052, EORTC-62061-STBSG, EORTC 62113-55115 HGUS, EORTC-62953, EORTC-62972, EORTC-90061-BI2536, EORTC STI571, EREMISS, ESTIM-LBH, ET-743, ETC-002-07, EURO-EWING, EURO-EWING 2012, EUROSARC, EZH-102 (EPIZYME), EZH-202, EZH-501, Far-RMS, FDH-609, FIVE PRIME, GCS O12, GEIS-32, GIGIST-LB, GIMATECAN, GO29664, GP28153, H6Q-MC-JCAY, I3G-MC-JGCB, I5B-MC-JGDJ : ANNOUNCE, I5B-MC-JGDL : ANNOUNCE 2, I5B-MC-JGDM, I6F-MC-JJCD, IDRX-42-001, IMCLONE, IMADGIST, INTRIGUE DCC 2618 03002, INVICTUS, ISI-JX, IROFULVEN, KCP-330-020 SEAL, KIDES-203, LEE011, LENVAGIST, LMS02, LMS03, LMS04, LOXO-TRAK, MDR-S9788, MEGAMOST, MEKi, MEN 10755, METRO-PD1, METROMAJX, METZOLIMOS, MK 7339, MK 7902-013, MK 8669-DALORI, ML43313-COTESARC, MMT 95, MO29518 basket, MOLMED, MORAb-004, MOST, MOST Plus, MULTISARC C16-40, NAVE-CYCLO, NB003-01, NBTXR3-301, NEOSARCOMICS, NP27872, NP28021, NVL-655-01, OP690, OS 2006, OSII-TTP, PAL-ANGI3, PALETTE, PALSAR, PALSAR II, PAZOGIST, PEAK, PEMBROSARC, PICASSO, PICASSO 3, PIPER, PLX108-10, PO4720, PRESOV, PVNS, RADIOSARP, RAR-IMMUNE, REGISTRI, REGO-SARC, REGOBONE, REGOMAIN, REGOMUNE, REGOSTA, RMS 2005, RT-IMMUNE, RT-SUTENT, SAKK 56/07, SAR-1001, SAR04/0205, SARC011 R1507, SARC021-THRESHOLD, SARCOME 13, SCH717454, SEAL-KCP-330-020 , SHIVA, STARTRK2, STARTRK GO40782, STI 571, STING GSK 208850, SU011248, SUCCEED, SYNFRIZZ, TAIL, TAPISTRY BO41932 , TAPPAS, TARMIC, TAXOGEM, T-DIS, TH-CR-406, TH302, TRAMUNE, TRAST, TRUST, TSAR, VEBASKET, VEG105430 , VINFLUNINE IN104, VIT-0910, XGEVA AMGEN
IndicSTTTLine
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
Neo-adjuvant, Adjuvant, Palliative, Maintenance
Progression chemo
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Yes: the patient had progressive disease at the date of last-follow up; no: no progressive disease observed at the date of last follow-up Possible values :
Yes, No, Not available
Date progression chemo
Type : Free value
Content : DATE
Mandatory : No
Multiple values : No
Unique : No		 Description : Date of tumour progression under chemotharapy
Best RECIST Response chemo
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Best response observed during chemotherapy: complete response; partial response; stable disease or progressive disease Possible values :
Complete response, Partial response, Stable disease, Progressive disease, Not evaluable

Immunohistochemistry (7 items)

Positive markers
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No		 Description : Possible values :
ACE, ALDH1, ALK, ALK D5F3, Alpha-Foetoprotein, Androgen R, AP2 BETA, BAP1, BCL1, BCL2, BCL6, BCOR, BerEP4, BerG1, Beta Catenin, Beta HCG, BHN9, Brachyury, BRAF, BRG1, c-KIT/CD117, c-MYC, CA 19-9, Caldesmon, Calponin, Calretinin, CAM5.2, CAMTA 1, CD1a, CD2, CD3, CD4, CD5, CD8, CD10, CD15, CD20, CD21, CD22, CD23, CD30, CD31, CD34, CD35, CD43, CD45, CD56, CD61, CD68, CD79, CD99, CD123, CD138, CD163, CDK4, CDX2, Chromagranin A, CK5, CK5/6, CK7, CK8, CK14, CK18, CK19, CK20, CK903 (34BE12:HMW), Claudin, Cmet, CMV, Collagen IV, Cyclin B3, Cyclin D1, Cytokeratin Kl1, D2-40, DEPAR 1, Desmin, DOG1, E-Cadherin, EBV (LMP), EGFr, EMA, ERG, Estrogen R, ETV4, EZH2, Factor VIII, Fos B , Fox2B, FoxL2, Fli1, FU-1, GATA3, GFAP, GLUT, Glycophorin A, Glypican-3, H3.3G34W (H3F3A), H3K36M (H3F3B), H3K27, HBK27, Helicobacter pylori, HER2, HHF35, HHV8, HIS EBER, HMB45, HMGA2, HNF1 Beta, IgD, IgG4, IgM, Inhibin, INI1, Ki67, KL1, MDM2, MDM4, MelanA, Mitf, MLH1, MSH2, MSH6, MUC4, Mum1, Myeloperoxydase, MYO D1, Myogenin, Nestin, Neurofilaments, NKIC3, NR3C4, NRAS (Q61R), NSE, NTRK1, NUT, NY-ESO1, OCT-4, OLIG2, P16, P40, P53, P63, Pan-Leu, Pancytokeratin AE1/AE3, PAX5, PAX8, PD-1, PD-L1, PDGFRA, PDGFRB, PDL1-E1L3N, Phospho-Histon, Phospho-S6, Phox2b, PKCteta, PLAP, PMS2, PNL2, Progesteron R, PSA, PTEN, RB1, RCC, ROS1, S100 Protein, Sall4, SATB2, SDHA, SDHB, SMA, SMARCA2, SMARCA4, SOX2, SOX9, SOX10, SOX11, SS18-SSX, STAT 6, Synaptophysin, TET1, TLE1, TFE3, Thyroglobulin, Ti A-1, TdT, Transgelin, TRK-PAN, TTF1, Vimentin, WT1
Positive focal markers
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No		 Description : Possible values :
ACE, ALDH1, ALK, ALK D5F3, Alpha-Foetoprotein, Androgen R, AP2 BETA, BAP1, BCL1, BCL2, BCL6, BCOR, BerEP4, BerG1, Beta Catenin, Beta HCG, BHN9, Brachyury, BRAF, BRG1, c-KIT/CD117, c-MYC, CA 19-9, Caldesmon, Calponin, Calretinin, CAM5.2, CAMTA 1, CD1a, CD2, CD3, CD4, CD5, CD8, CD10, CD15, CD20, CD21, CD22, CD23, CD30, CD31, CD34, CD35, CD43, CD45, CD56, CD61, CD68, CD79, CD99, CD123, CD138, CD163, CDK4, CDX2, Chromagranin A, CK5, CK5/6, CK7, CK8, CK14, CK18, CK19, CK20, CK903 (34BE12:HMW), Claudin, Cmet, CMV, Collagen IV, Cyclin B3, Cyclin D1, Cytokeratin Kl1, D2-40, DEPAR 1, Desmin, DOG1, E-Cadherin, EBV (LMP), EGFr, EMA, ERG, Estrogen R, ETV4, EZH2, Factor VIII, Fli1, Fos B , Fox2B, FoxL2, FU-1, GATA3, GFAP, GLUT, Glycophorin A, Glypican-3, H3.3G34W (H3F3A), H3K36M (H3F3B), H3K27, HBK27, Helicobacter pylori, HER2, HHF35, HHV8, HIS EBER, HMB45, HMGA2, HNF1 Beta, IgD, IgG4, IgM, Inhibin, INI1, Pancytokeratin AE1/AE3, KL1, MDM2, MDM4, MelanA, Mitf, MLH1, MSH2, MSH6, MUC4, Mum1, Myeloperoxydase, MYO D1, Myogenin, Nestin, Neurofilaments, NKIC3, NR3C4, NRAS (Q61R), NSE, NTRK1, NUT, NY-ESO1, OCT-4, OLIG2, P16, P40, P53, P63, Pan-Leu, PAX5, PAX8, PD-1, PD-L1, PDGFRA, PDGFRB, PDL1-E1L3N, Phospho-Histon, Phospho-S6, Phox2b, PKCteta, PLAP, PMS2, PNL2, Progesteron R, PSA, PTEN, RB1, RCC, ROS1, S100 Protein, Sall4, SATB2, SDHA, SDHB, SMA, SMARCA2, SMARCA4, SOX2, SOX9, SOX10, SOX11, SS18-SSX, STAT 6, Synaptophysin, TET1, TLE1, TFE3, Thyroglobulin, Ti A-1, TdT, Transgelin, TRK-PAN, TTF1, Vimentin, WT1
Positive diffuse markers
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No		 Description : Possible values :
ACE, ALDH1, ALK, ALK D5F3, Alpha-Foetoprotein, Androgen R, AP2 BETA, BAP1, BCL1, BCL2, BCL6, BCOR, BerEP4, BerG1, Beta Catenin, Beta HCG, BHN9, Brachyury, BRAF, BRG1, c-KIT/CD117, c-MYC, CA 19-9, Caldesmon, Calponin, Calretinin, CAM5.2, CAMTA 1, CD1a, CD2, CD3, CD4, CD5, CD8, CD10, CD15, CD20, CD21, CD22, CD23, CD30, CD31, CD34, CD35, CD43, CD45, CD56, CD61, CD68, CD79, CD99, CD123, CD138, CD163, CDK4, CDX2, Chromagranin A, CK5, CK5/6, CK7, CK8, CK14, CK18, CK19, CK20, CK903 (34BE12:HMW), Claudin, Cmet, CMV, Collagen IV, Cyclin B3, Cyclin D1, Cytokeratin Kl1, D2-40, DEPAR 1, Desmin, DOG1, EBV (LMP), E-Cadherin, EGFr, EMA, HHF35, ERG, Estrogen R, ETV4, EZH2, Factor VIII, Fli1, Fos B , Fox2B, FoxL2, FU-1, GATA3, GFAP, GLUT, Glycophorin A, Glypican-3, H3.3G34W (H3F3A), H3K27, H3K36M (H3F3B), HBK27, Helicobacter pylori, HER2, HHV8, HIS EBER, HMB45, HMGA2, HNF1 Beta, IgD, IgG4, IgM, Inhibin, INI1, KL1, MDM2, MDM4, MelanA, Mitf, MLH1, MSH2, MSH6, MUC4, Mum1, Myeloperoxydase, MYO D1, Myogenin, Nestin, Neurofilaments, NKIC3, NR3C4, NRAS (Q61R), NSE, NTRK1, NUT, NY-ESO1, OCT-4, OLIG2, P16, P40, P53, P63, Pan-Leu, Pancytokeratin AE1/AE3, PAX5, PAX8, PD-1, PD-L1, PDGFRA, PDGFRB, PDL1-E1L3N, Phospho-Histon, Phospho-S6, Phox2b, PKCteta, PLAP, PMS2, PNL2, Progesteron R, PSA, PTEN, RB1, RCC, ROS1, S100 Protein, Sall4, SATB2, SDHA, SDHB, SMA, SMARCA2, SMARCA4, SOX2, SOX9, SOX10, SOX11, SS18-SSX, STAT 6, Synaptophysin, TET1, TLE1, TFE3, Thyroglobulin, Ti A-1, TdT, Transgelin, TRK-PAN, TTF1, Vimentin, WT1
Negative markers
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No		 Description : Possible values :
ACE, ALDH1, ALK, ALK D5F3, Alpha-Foetoprotein, Androgen R, AP2 BETA, BAP1, BCL1, BCL2, BCL6, BCOR, BerEP4, BerG1, Beta Catenin, Beta HCG, BHN9, Brachyury, BRAF, BRG1, c-KIT/CD117, c-MYC, CA 19-9, Caldesmon, Calponin, Calretinin, CAM5.2, CAMTA 1, CD1a, CD2, CD3, CD4, CD5, CD8, CD10, CD15, CD20, CD21, CD22, CD23, CD30, CD31, CD34, CD35, CD43, CD45, CD56, CD61, CD68, CD79, CD99, CD123, CD138, CD163, CDK4, CDX2, Chromagranin A, CK5, CK5/6, CK7, CK8, CK14, CK18, CK19, CK20, CK903 (34BE12:HMW), Claudin, Cmet, CMV, Collagen IV, Cyclin B3, Cyclin D1, Cytokeratin Kl1, D2-40, DEPAR 1, Desmin, DOG1, E-Cadherin, EBV (LMP), EGFr, EMA, ERG, Estrogen R, ETV4, EZH2, Factor VIII, Fli1, Fos B , Fox2B, FoxL2, FU-1, GATA3, GFAP, GLUT, Glycophorin A, Glypican-3, H3.3G34W (H3F3A), H3K27, H3K36M (H3F3B), HBK27, Helicobacter pylori, HER2, HHF35, HHV8, HIS EBER, HMB45, HMGA2, HNF1 Beta, IgD, IgG4, IgM, Inhibin, INI1, Ki67, KL1, MDM2, MDM4, MelanA, Mitf, MLH1, MSH2, MSH6, MUC4, Mum1, Myeloperoxydase, MYO D1, Myogenin, Nestin, Neurofilaments, NKIC3, NRAS (Q61R), NSE, NR3C4, NTRK1, NUT, NY-ESO1, OCT-4, OLIG2, P16, P40, P53, P63, Pan-Leu, Pancytokeratin AE1/AE3, PAX5, PAX8, PD-1, PD-L1, PDGFRA, PDGFRB, PDL1-E1L3N, Phospho-Histon, Phospho-S6, Phox2b, PKCteta, PLAP, PMS2, PNL2, Progesteron R, PSA, PTEN, RB1, RCC, ROS1, S100 Protein, Sall4, SATB2, SDHA, SDHB, SMA, SMARCA2, SMARCA4, SOX2, SOX9, SOX10, SOX11, STAT 6, SS18-SSX, Synaptophysin, TET1, TLE1, TFE3, Thyroglobulin, Ti A-1, TdT, Transgelin, TRK-PAN, TTF1, Vimentin, WT1
Not interpretable markers
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No		 Description : Possible values :
ACE, ALDH1, ALK, ALK D5F3, Alpha-Foetoprotein, Androgen R, AP2 BETA, BAP1, BCL1, BCL2, BCL6, BCOR, BerEP4, BerG1, Beta Catenin, Beta HCG, BHN9, Brachyury, BRAF, BRG1, c-KIT/CD117, c-MYC, CA 19-9, Caldesmon, Calponin, Calretinin, CAM5.2, CAMTA 1, CD1a, CD2, CD3, CD4, CD5, CD8, CD10, CD15, CD20, CD21, CD22, CD23, CD30, CD31, CD34, CD35, CD43, CD45, CD56, CD61, CD68, CD79, CD99, CD123, CD138, CD163, CDK4, CDX2, Chromagranin A, CK5, CK5/6, CK7, CK8, CK14, CK18, CK19, CK20, CK903 (34BE12:HMW), Claudin, Cmet, CMV, Collagen IV, Cyclin B3, Cyclin D1, Cytokeratin Kl1, D2-40, DEPAR 1, Desmin, DOG1, E-Cadherin, EBV (LMP), EGFr, EMA, ERG, Estrogen R, ETV4, EZH2, Factor VIII, Fli1, Fos B , Fox2B, FoxL2, FU-1, GATA3, GFAP, GLUT, Glycophorin A, Glypican-3, H3.3G34W (H3F3A), H3K27, H3K36M (H3F3B), HBK27, Helicobacter pylori, HER2, HHF35, HHV8, HIS EBER, HMB45, HMGA2, HNF1 Beta, IgD, IgG4, IgM, Inhibin, INI1, Ki67, KL1, MDM4, MDM2, MelanA, Mitf, MLH1, MSH2, MSH6, MUC4, Mum1, Myeloperoxydase, MYO D1, Myogenin, Nestin, Neurofilaments, NKIC3, NR3C4, NRAS (Q61R), NSE, NTRK1, NUT, NY-ESO1, OCT-4, OLIG2, P16, P40, P53, P63, Pan-Leu, Pancytokeratin AE1/AE3, PAX5, PAX8, PD-1, PD-L1, PDGFRA, PDGFRB, PDL1-E1L3N, Phospho-Histon, Phospho-S6, Phox2b, PKCteta, PLAP, PMS2, PNL2, Progesteron R, PSA, PTEN, RB1, RCC, ROS1, S100 Protein, Sall4, SATB2, SDHA, SDHB, SMA, SMARCA2, SMARCA4, SOX2, SOX9, SOX10, SOX11, STAT 6, SS18-SSX, Synaptophysin, TET1, TLE1, TFE3, Thyroglobulin, Ti A-1, TdT, Transgelin, TRK-PAN, TTF1, Vimentin, WT1
Mib1%
Type : Free value
Content : PERCENTAGE
Mandatory : No
Multiple values : No
Unique : No		 Description :
Other markers
Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description :

Molecular cytogenetics (76 items)

Translocation analysis
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
Yes, No
GNAS status
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
Mutation, No mutation, No amplifiable DNA
TypeTechGNAS
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
DHPLC, Sequencing, Both, Other
RT-PCR
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
No, Yes
Positive transcript (RT-PCR)
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No		 Description : Possible values :
Transcript (PNET), EWSR1-FLI1 (PNET), EWSR1-ERG (PNET), EWSR1-ETV1 (PNET), EWSR1-FEV (PNET), EWSR1-ETV4 (PNET), FUS-ERG (PNET), CIC-DUX4 (Ewing -like), BCOR-CCNB3 (Ewing-like), Transcript (synovial sarcoma), SSI8-SSX1 (synovial sarcoma), SSI8-SSX2 (synovial sarcoma), SSI8-SSX4 (synovial sarcoma), SSI8L1-SSX1 (synovial sarcoma), Transcript (alveolar rhabdomyosarcoma), PAX3-FOXOA1 (alveolar rhabdomyosarcoma), PAX7-FOXOA1 (alveolar rhabdomyosarcoma), PAX3-MLLT7 (alveolar rhabdomyosarcoma), PAX3-NCOA1 (alveolar rhabdomyosarcoma), EWSR1-WT1 (desmoplastic round cell tumour), Transcript (myxoid liposarcoma), FUS-DDIT3 (myxoid liposarcoma), EWSR1-DDIT3 (myxoid liposarcoma), EWSR1-ATF1 (clear cell sarcoma), Transcript (extraskeletal myxoid chondrosarcoma), EWSR1-NR4A3 (extraskeletal myxoid chondrosarcoma), TAF1168-NR4A3 (extraskeletal myxoid chondrosarcoma), TCF12-NR4A3 (extraskeletal myxoid chondrosarcoma), TFG-NR4A3 (extraskeletal myxoid chondrosarcoma), COL1A1-PDGFB (dermatofibrosarcoma protuberans), Transcript (low grade fibromyxoid sarcoma), FUS-CREB3L2 (low grade fibromyxoid sarcoma), FUS-CREB3L1 (low grade fibromyxoid sarcoma), ASPL-TFE3 (alveolar soft part sarcoma), ASPSCR1-TFE3 (alveolar soft part sarcoma), ETV6-NTRK3 (congenital fibrosarcoma), Transcript (endometrial stromal sarcoma), JAZF1/SUZ12 (endometrial stromal sarcoma), YWHAE-FAM22 (endometrial stromal sarcoma), YWHAE-NUTM22A/B (endometrial stromal sarcoma), PAX-MAML3 (sinonasal sarcoma) , PAX3-NCOA1 (sinonasal sarcoma), MYH9-USP6 (fasciitis), EWSR1-PATZ1, EWSR1-ETAF1, CLTC-ALK, hSNF5/INI1 (malignant rhabdoid tumors), EWSR1-CREB3L2, NAB2-STAT6, SRF-NCOA1, FUS/FEV, EWS/NFATc2, EWSR1-CREB1, WWTR1-CAMTA1
Negative transcript (RT-PCR)
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No		 Description : Possible values :
Transcript (PNET), EWSR1-FLI1 (PNET), EWSR1-ERG (PNET), EWSR1-ETV1 (PNET), EWSR1-FEV (PNET), EWSR1-ETV4 (PNET), FUS-ERG (PNET), CIC-DUX4 (Ewing -like), BCOR-CCNB3 (Ewing-like), Transcript (synovial sarcoma), SSI8-SSX1 (synovial sarcoma), SSI8-SSX2 (synovial sarcoma), SSI8-SSX4 (synovial sarcoma), SSI8L1-SSX1 (synovial sarcoma), Transcript (alveolar rhabdomyosarcoma), PAX3-FOXOA1 (alveolar rhabdomyosarcoma), PAX7-FOXOA1 (alveolar rhabdomyosarcoma), PAX3-MLLT7 (alveolar rhabdomyosarcoma), PAX3-NCOA1 (alveolar rhabdomyosarcoma), EWSR1-WT1 (desmoplastic round cell tumour), Transcript (myxoid liposarcoma), FUS-DDIT3 (myxoid liposarcoma), EWSR1-DDIT3 (myxoid liposarcoma), EWSR1-ATF1 (clear cell sarcoma), Transcript (extraskeletal myxoid chondrosarcoma), EWSR1-NR4A3 (extraskeletal myxoid chondrosarcoma), TAF1168-NR4A3 (extraskeletal myxoid chondrosarcoma), TCF12-NR4A3 (extraskeletal myxoid chondrosarcoma), TFG-NR4A3 (extraskeletal myxoid chondrosarcoma), COL1A1-PDGFB (dermatofibrosarcoma protuberans), Transcript (low grade fibromyxoid sarcoma), FUS-CREB3L2 (low grade fibromyxoid sarcoma), FUS-CREB3L1 (low grade fibromyxoid sarcoma), ASPL-TFE3 (alveolar soft part sarcoma), ASPSCR1-TFE3 (alveolar soft part sarcoma), ETV6-NTRK3 (congenital fibrosarcoma), Transcript (endometrial stromal sarcoma), JAZF1/SUZ12 (endometrial stromal sarcoma), YWHAE-FAM22 (endometrial stromal sarcoma), YWHAE-NUTM22A/B (endometrial stromal sarcoma), PAX-MAML3 (sinonasal sarcoma) , PAX3-NCOA1 (sinonasal sarcoma), MYH9-USP6 (fasciitis), EWSR1-ETAF1, EWSR1-PATZ1, CLTC-ALK, hSNF5/INI1 (malignant rhabdoid tumors), EWSR1-CREB3L2, NAB2-STAT6, SRF-NCOA1, FUS/FEV, EWS/NFATc2, EWSR1-CREB1, WWTR1-CAMTA1
Non interpretable transcript (RT-PCR)
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No		 Description : Possible values :
Transcript (PNET), EWSR1-FLI1 (PNET), EWSR1-ERG (PNET), EWSR1-ETV1 (PNET), EWSR1-FEV (PNET), EWSR1-ETV4 (PNET), FUS-ERG (PNET), CIC-DUX4 (Ewing -like), BCOR-CCNB3 (Ewing-like), Transcript (synovial sarcoma), SSI8-SSX1 (synovial sarcoma), SSI8-SSX2 (synovial sarcoma), SSI8-SSX4 (synovial sarcoma), SSI8L1-SSX1 (synovial sarcoma), Transcript (alveolar rhabdomyosarcoma), PAX3-FOXOA1 (alveolar rhabdomyosarcoma), PAX7-FOXOA1 (alveolar rhabdomyosarcoma), PAX3-MLLT7 (alveolar rhabdomyosarcoma), PAX3-NCOA1 (alveolar rhabdomyosarcoma), EWSR1-WT1 (desmoplastic round cell tumour), Transcript (myxoid liposarcoma), FUS-DDIT3 (myxoid liposarcoma), EWSR1-DDIT3 (myxoid liposarcoma), EWSR1-ATF1 (clear cell sarcoma), Transcript (extraskeletal myxoid chondrosarcoma), EWSR1-NR4A3 (extraskeletal myxoid chondrosarcoma), TAF1168-NR4A3 (extraskeletal myxoid chondrosarcoma), TCF12-NR4A3 (extraskeletal myxoid chondrosarcoma), TFG-NR4A3 (extraskeletal myxoid chondrosarcoma), COL1A1-PDGFB (dermatofibrosarcoma protuberans), Transcript (low grade fibromyxoid sarcoma), FUS-CREB3L2 (low grade fibromyxoid sarcoma), FUS-CREB3L1 (low grade fibromyxoid sarcoma), ASPL-TFE3 (alveolar soft part sarcoma), ASPSCR1-TFE3 (alveolar soft part sarcoma), ETV6-NTRK3 (congenital fibrosarcoma), Transcript (endometrial stromal sarcoma), JAZF1/SUZ12 (endometrial stromal sarcoma), YWHAE-FAM22 (endometrial stromal sarcoma), YWHAE-NUTM22A/B (endometrial stromal sarcoma), PAX-MAML3 (sinonasal sarcoma) , PAX3-NCOA1 (sinonasal sarcoma), MYH9-USP6 (fasciitis), EWSR1-PATZ1, EWSR1-ETAF1, CLTC-ALK, hSNF5/INI1 (malignant rhabdoid tumors), EWSR1-CREB3L2, NAB2-STAT6, SRF-NCOA1, FUS/FEV, EWS/NFATc2, EWSR1-CREB1, WWTR1-CAMTA1
FISH
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : FISH performed Possible values :
No, Yes
Positive (FISH)
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No		 Description : Possible values :
EWSR1 (BA), SSI8 (BA), FOXOA1 (BA), FUS (BA), DDIT3 (BA), ETV6 (BA), PDGFB (BA), COL1A1- PDGFB (fusion), CIC (BA), USP6 (BA), PHF1 (BA), TFE3 (BA), YWHAE (BA), JAZF1 (BA), CAMTA1-WWTR1 (Fusion), ALK (BA), PAX3 (BA), NCOA2 (BA), NR4A3 (BA), H3.3G34W (H3F3A), H3K36M (H3F3B), IDH1/IDH2, GNAS, BCOR, CCNB3, EWSR1-FLI1, EWSR1-ERG, WWTR1 (BA), CKN2A (P16), CAMTA1 (BA), SRF, WT1, NTRK3, VGLL3, CSF1, COL1A1, MGEA5, PTEN, SMARCB1 (INI1), ROS1, RET, CIC-DUX4, PLAG1, NUTM1, FOSB, ERG, BRAF, VGLL2, MAP3K3, WWTR1-CAMTA1 (Fusion), NAFTC3, PRDM10, GRM1, TFCP2, NTRK1, USP2, YAP1, TRIM11, HMGA2, RB1, FN1, APOD, FGFR1, PRKCD
Negative (FISH)
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No		 Description : Possible values :
EWSR1 (BA), SSI8 (BA), FOXOA1 (BA), FUS (BA), DDIT3 (BA), ETV6 (BA), PDGFB (BA), COL1A1- PDGFB (fusion), CIC (BA), JAZF1 (BA), USP6 (BA), PHF1 (BA), TFE3 (BA), YWHAE (BA), CAMTA1-WWTR1 (Fusion), ALK (BA), PAX3 (BA), NCOA2 (BA), NR4A3 (BA), H3.3G34W (H3F3A), H3K36M (H3F3B), IDH1/IDH2, GNAS, BCOR, CCNB3, EWSR1-ERG, EWSR1-FLI1, WWTR1 (BA), CKN2A (P16), CAMTA1 (BA), SRF, WT1, NTRK3, VGLL3, CSF1, COL1A1, MGEA5, PTEN, SMARCB1 (INI1), ROS1, RET, CIC-DUX4, PLAG1, NUTM1, FOSB, HMGA2, ERG, BRAF, VGLL2, MAP3K3, WWTR1-CAMTA1 (Fusion), NAFTC3, PRDM10, GRM1, TFCP2, NTRK1, USP2, YAP1, TRIM11, RB1, FN1, APOD, FGFR1, PRKCD
Non interpretable (FISH)
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No		 Description : Possible values :
CIC (BA), COL1A1- PDGFB (fusion), DDIT3 (BA), ETV6 (BA), EWSR1 (BA), FOXOA1 (BA), FUS (BA), PDGFB (BA), PHF1 (BA), JAZF1 (BA), SSI8 (BA), TFE3 (BA), USP6 (BA), YWHAE (BA), CAMTA1-WWTR1 (Fusion), ALK (BA), PAX3 (BA), NCOA2 (BA), NR4A3 (BA), H3.3G34W (H3F3A), H3K36M (H3F3B), IDH1/IDH2, GNAS, BCOR, CCNB3, EWSR1-FLI1, EWSR1-ERG, WWTR1 (BA), CAMTA1 (BA), CKN2A (P16), SRF, WT1, NTRK3, VGLL3, CSF1, COL1A1, MGEA5, PTEN, SMARCB1 (INI1), ROS1, RET, CIC-DUX4, PLAG1, NUTM1, FOSB, ERG, BRAF, VGLL2, MAP3K3, WWTR1-CAMTA1 (Fusion), NAFTC3, PRDM10, GRM1, TFCP2, NTRK1, USP2, YAP1, TRIM11, RB1, HMGA2, FN1, APOD, FGFR1, PRKCD
GenesMut
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No		 Description : Possible values :
APC, BRAF, CTNNB1, GNAS, H3F3A, H3F3B, INI1, KIT, MYOD1, NF1, PDGFRA, SDHA, SDHB, SDHC, SDHD, SMARCA4, SMARCB1, TP53, Other
OtherGenesMut
Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description :
APC status
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
Mutation, No mutation, Non amplifiable DNA
TypeTechAPC
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
DHPLC, Sequencing, Both, Other
BRAF status
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
V600E, Other, No mutation, Non amplifiable DNA
TypeTechBRAF
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
DHPLC, Sequencing, Both, Other
Exon 3 status (CTNNB1)
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
41A mutation, 45F mutation, 45P mutation, Other mutation, No mutation, Non amplifiable DNA
TypeTechCTNNB1
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
DHPLC, Sequencing, Both, Other
H3F3A status
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
Mutation, No mutation, No amplifiable DNA
TypeTechH3F3A
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
DHPLC, Sequencing, Both, Other
H3F3B status
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
Mutation, No mutation, No amplifiable DNA
TypeTechH3F3B
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
DHPLC, Sequencing, Both, Other
INI1 status
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
Mutation, No mutation, Non amplifiable DNA
TypeTechINI1
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
DHPLC, Sequencing, Both, Other
KIT status
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No		 Description : Possible values :
Exon9, Exon11, Exon13, Exon17, Other exon, No mutation, No amplifiable DNA
TypeTechKIT
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
DHPLC, Sequencing, Both, Other
KIT Nucleotidic formula exon 9
Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description :
KIT Proteic formula exon 9
Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description :
KIT Nucleotidic formula exon 11
Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description :
KIT Proteic formula exon 11
Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description :
KIT Nucleotidic formula exon 13
Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description :
KIT Proteic formula exon 13
Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description :
KIT Nucleotidic formula exon 17
Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description :
KIT Proteic formula exon 17
Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description :
MYOD1 status
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
Mutation, No mutation, No amplifiable DNA
TypeTechMYOD1
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
DHPLC, Sequencing, Both, Other
NF1 status
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
Mutation, No mutation, No amplifiable DNA
TypeTechNF1
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
DHPLC, Sequencing, Both, Other
PDGFRA status
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No		 Description : Possible values :
Exon12, Exon14, Exon18, Other exon, No mutation, No amplifiable DNA
TypeTechPDGFRA
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
DHPLC, Sequencing, Both, Other
PDGFRA Nucleotidic formula exon 12
Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description :
PDGFRA Proteic formula exon 12
Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description :
PDGFRA Nucleotidic formula exon 14
Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description :
PDGFRA Proteic formula exon 14
Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description :
PDGFRA Nucleotidic formula exon 18
Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description :
PDGFRA Proteic formula exon 18
Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description :
SDHA status
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
Mutation, No mutation, No amplifiable DNA
TypeTechSDHA
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
DHPLC, Sequencing, Both, Other
SDHB status
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
Mutation, No mutation, No amplifiable DNA
TypeTechSDHB
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
DHPLC, Sequencing, Both, Other
SDHC status
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
Mutation, No mutation, No amplifiable DNA
TypeTechSDHC
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
DHPLC, Sequencing, Both, Other
SDHD status
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
Mutation, No mutation, No amplifiable DNA
TypeTechSDHD
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
DHPLC, Sequencing, Both, Other
SMARCA4 status
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
Mutation, No mutation, No amplifiable DNA
TypeTechSMARCA4
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
DHPLC, Sequencing, Both, Other
SMARCB1 status
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
Mutation, No mutation, No amplifiable DNA
TypeTechSMARCB1
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
DHPLC, Sequencing, Both, Other
P53 mutation status
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
Mutation, No mutation, Non amplifiable DNA
TypeTechTP53
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
Sequencing, Functional assay, Both, Other
P53 nucleotidic formula 1
Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description :
P53 proteic formula 1
Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description :
P53 nucleotidic formula 2
Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description :
P53 proteic formula 2
Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description :
Amplification analysis
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
Yes, No
GenesAmp
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : Yes
Unique : No		 Description : Possible values :
CDK4, CMYC, MDM2, Other
OtherGenesAmp
Type : Free value
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description :
Result CDK4
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
Negative, Positive, Non interpretable
TypeTechCDK4
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
FISH, Q-PCR, Array-CGH, Other
ResultCMYC
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
Negative, Positive, Non interpretable
TypeTechCMYC
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
FISH, Q-PCR, Array-CGH, Other
Result MDM2
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
Negative, Positive, Non interpretable
TypeTechMDM2
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
FISH, Q-PCR, Array-CGH, Other
P53 polymorphism
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
Yes, No
P53 functional status
Type : Constrained
Content : TEXT
Mandatory : No
Multiple values : No
Unique : No		 Description : Possible values :
WT, Mut